UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, D.C. 20549

FORM 10-K

~~[X]~~ þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June ~~March 31~~30, ~~2009~~2010

or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~[ ]~~For ~~TRANSITION~~the ~~REPORT~~transition ~~UNDER~~period ~~SECTION~~from _________ 13to ~~OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~_________

~~For~~Commission ~~the~~file ~~transition~~number ~~period from _________________ to __________________~~0-12968

~~Commission~~SUNRIDGE ~~file~~INTERNATIONAL, ~~number: 001-31669~~INC.

~~TARI~~(Exact ~~INC.~~name of registrant as specified in its charter)

(Exact name of Registrant as specified in its charter)

Nevada	98-0348905
(State of Incorporation)	(I.R.S. Employer Identification No.)

Nevada	98-0348905
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

16857 E. Saguaro Blvd.

1029 Logan Avenue, Toronto, Ontario Canada	M4K 3E7
(Address of principal executive offices)	(Zip Code)

Fountain Hills, Arizona 85268

~~Registrant’s~~(Address ~~telephone~~of ~~number,~~principal ~~including~~executive ~~area code (416~~offices) ~~406-5502~~

~~Securities registered pursuant to Section 12~~(b480) ~~of the Act:~~837-6165

~~Title~~(Registrant’s oftelephone ~~each~~number, ~~class~~including toarea ~~be so registered Name of each exchange on which each class is to be registered None None~~code)

~~Securities~~(Former toname, beformer ~~registered~~address ~~pursuant~~and toformer ~~Section~~fiscal ~~12(g)~~year, ofif ~~the~~changed ~~Act:~~since last report)

~~Common~~Securities ~~Stock,~~Registered ~~Par~~Pursuant ~~Value~~to ~~$0.001~~Section 12(b) of the Act: None

(Title of Class)

Securities Registered Pursuant to Section 12(g) of the Act:

Title of Each Class	Name of Each Exchange on which Registered

Common Stock, $.001 par value	None

1Table of Contents

~~Indicate~~Index byto ~~check~~Financial ~~mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.~~Statements

oIndicate ~~Yes~~by þcheck mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ

oIndicate ~~Yes~~by þcheck mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

~~Note~~Indicate –by ~~Checking~~check mark whether the ~~box~~registrant ~~above~~has ~~will~~submitted ~~not~~electronically ~~relieve~~and posted on its corporate Web site, if any, ~~registrant~~every Interactive Data File required to ~~file~~be ~~reports~~submitted and posted pursuant to ~~Section~~Rule 13405 orof 15Regulation S-T (d)§ 232.405 of this chapter) during the ~~Exchange~~preceding ~~Act~~12 ~~from~~months ~~their~~(or ~~obligations~~for ~~under~~such ~~those~~shorter ~~Sections~~period that the registrant was required to submit and post such files). Yes o No þ

Indicate by check mark ~~whether~~if ~~the~~disclosure ~~registrant~~of ~~(1)~~delinquent ~~has~~filers ~~filed~~pursuant ~~all reports required~~ to beItem ~~filed~~405 byof ~~Section~~Regulation 13S-K ~~or 15~~(d)§ 229.405 of ~~the~~this ~~Securities~~chapter) ~~Exchange~~is ~~Act~~not ofcontained ~~1934~~herein, ~~during~~and ~~the~~will ~~preceding~~not 12be ~~months~~contained, ~~(or~~to ~~for~~the ~~such~~best ~~shorter~~of ~~period~~registrant’s ~~that~~knowledge, ~~the~~in ~~registrant~~definitive ~~was~~proxy ~~required~~or toinformation ~~file~~statements ~~such~~incorporated ~~reports),~~by ~~and~~reference ~~(2)~~in ~~has~~Part ~~been~~III ~~subject~~of tothis ~~such~~Form ~~filing~~10-K ~~requirements~~or ~~for~~any ~~the~~amendment ~~past~~to 90this ~~days~~Form 10-K. þ

þIndicate ~~Yes~~by ocheck Nomark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

~~Indicate~~Large byaccelerated ~~check~~filer ~~mark~~o ~~whether~~Accelerated ~~the~~filer ~~registrant~~o ~~has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S~~Non-Taccelerated ~~(§229.405~~filer ofo ~~this~~Smaller ~~chapter)~~reporting ~~during~~company ~~the preceeding 12 months (or for such shorter period that the registrant was required to submit and post such files)~~þ

þIndicate ~~Yes~~by ocheck mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No þ

~~Indicate~~State bythe ~~check~~aggregate ~~mark~~market ifvalue ~~disclosure~~ of ~~delinquent~~the ~~filers~~voting ~~pursuant~~and ~~to Item 405 of Regulation S~~non-Kvoting ~~(§229.405~~common ofequity ~~this~~held ~~chapter)~~by ~~is not contained herein~~non-affiliates: $1,237,997 ~~and~~based ~~will~~on ~~not~~non-affiliate beshares ~~contained,~~outstanding toat ~~the~~$.09 ~~best~~per ~~of registrant’s knowledge~~share, inwhich ~~definitive~~is ~~proxy~~the orbid ~~information~~price ~~statements~~of ~~incorporated~~the bycommon ~~reference~~shares inas ~~Part III~~ of ~~this~~November ~~Form~~11, ~~10-K or any amendment to this Form 10-K~~2010.

þIndicate ~~Yes~~the onumber Noof shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 45,329,816 shares of common stock, $.001 par value, as of November 11, 2010.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

þ Yes ¨ No

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.

N/A

Note. – If a determination as to whether a particular person or entity is an affiliate cannot be made without involving unreasonable effort and expense, the aggregate market value of the common stock held by non-affiliates may be calculated on the basis of assumptions reasonable under the circumstances, provided that the assumptions are set forth in this Form

APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY

~~PROCEEDINGS~~Table ~~DURING~~of ~~THE PRECEDING FIVE YEARS:~~Contents

~~Indicate~~Index ~~by check mark whether the registrant has filed all documents and reports required~~ to beFinancial ~~filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.~~ Statements

oSUNRIDGE ~~Yes~~INTERNATIONAL, ~~o No~~INC.

~~(APPLICABLE~~ANNUAL ~~ONLY~~REPORT TOON ~~CORPORATE~~FORM ~~REGISTRANTS)~~10-K

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

3,890,000 as at June 23, 2009

DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424 (b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).

TABLE OF CONTENTS

Page ITEM 1: BUSINESS 5 ITEM 1A: RISK FACTORS 5 ITEM 1B: UNRESOLVED STAFF COMMENTS 9 ITEM 2: PROPERTIES 9 ITEM 3: LEGAL PROCEEDINGS 9 ITEM 4: SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS 9 ITEM 5: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 9 ITEM 6: SELECTED FINANCIAL DATA 10 ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 10 ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 10 ITEM 8: FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 10 ITEM 9: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES 28 ITEM 9A(T): CONTROLS AND PROCEDURES 28 ITEM 9B: OTHER INFORMATION 29 ITEM 10: DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 29 ITEM 11: EXECUTIVE COMPENSATION 30 ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 30 ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 30 ITEM 14: PRINCIPAL ACCOUNTANT FEES AND SERVICES 31 ITEM 15: EXHIBITS, FINANCIAL STATEMENT SCHEDULES 31

		Page

Forward-Looking Statements		4

PART 1

Item 1.	Business	5
Item 1A.	Risk Factors	10
Item 1B.	Unresolved Staff Comments	10
Item 2.	Properties	10
Item 3.	Legal Proceedings	10
Item 4	(Removed and Reserved)	11

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	12
Item 6.	Selected Financial Data	13
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	15
Item 8.	Financial Statements and Supplementary Data	16
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	34
Item 9A.	Controls and Procedures	34
Item 9B.	Other Information	35

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	36
Item 11.	Executive Compensation	39
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	40
Item 13.	Certain Relationships and Related Transactions and Director Independence	41
Item 14.	Principal Accounting Fees and Services	42

PART IV

Item 15.	Exhibits and Financial Statement Schedules	43

Signatures		44

Table of Contents

Index to Financial Statements

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K (“Annual Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and should be read in conjunction with the Financial Statements of SunRidge International, Inc., formerly known as TARI, Inc. (the “Company,” “SunRidge” or “TARI”). Such statements are not historical facts and reflect our current views regarding matters such as operations and financial performance. In general, forward-looking statements are identified by such words or phrases as “expects,” “anticipates,” “believes,” “could,” “approximates,” “estimates,” “may,” “intends,” “predicts,” “projects,” “plans,” or “will,” or the negative of those words or other terminology. These statements are not guarantees of future performance and involve certain known and unknown inherent risks, uncertainties and other factors that are difficult to predict; our actual results could differ materially from those expressed in these forward-looking statements, including those risks and other factors described elsewhere in this Annual Report. The cautionary factors, risks and other factors presented should not be construed as exhaustive. Other risks not presently known to us, or that we currently believe are immaterial, could also adversely affect our business, financial condition or results of operations.

Table of Contents

Index to Financial Statements

PART I

ITEM 1.

BUSINESS

~~In General~~Overview

WeAmendments are a pre-exploration stage company. We acquired a mining lease on a total of two unpatented lode mineral claims property located in the State of Nevada and the lease has been voided during the prior year. We are investigating projects and potential acquisition opportunities in order to ~~engage~~Articles ~~in the acquisition and exploration~~ of ~~mineral properties with a view to exploiting mineral deposits demonstrating economic feasibility.~~Incorporation

~~Employees~~On July 1, 2009, our Board of Directors approved an amendment to our Articles of Incorporation to change our name from TARI, Inc. to Sunridge International Inc. This resolution was approved by our majority shareholder on July 10, 2009. This amendment to our Articles of Incorporation was filed with the Secretary of State of Nevada on July 23, 2009. This name change was approved by the Financial Industry Regulatory Authority (“FINRA”) on September 23, 2009.

WeOn ~~have~~July no1, ~~employees~~2009, asour Board of ~~the~~Directors ~~date~~approved an amendment to our Articles of ~~this~~Incorporation ~~annual~~to ~~report~~increase ~~other~~our ~~than~~authorized ~~Mr.~~common ~~Theodore~~stock ~~Tsagkaris~~from 100,000,000 ~~the~~to ~~president~~550,000,000 shares, to increase our authorized preferred stock from 10,000,000 to 50,000,000 shares, and ~~sole~~to ~~director~~increase our outstanding common stock shares from 3,890,000 to 19,450,000 shares. This amendment to our Articles of Incorporation was filed with the Secretary of State of Nevada on August 4, 2009. This 5-to-1 forward split was approved by FINRA on September 23, 2009.

~~Research~~Share ~~and~~Exchange ~~Development Expenditures~~Agreement

WeOn ~~have~~September ~~incurred~~5, ~~exploration~~2009, ~~expenditures~~we entered into an Agreement of Share Exchange and Plan of Reorganization (the “Share Exchange Agreement”) and consummated a share exchange (the “Share Exchange”) with Ophthalmic International, Inc. (“OI”), a Nevada corporation. The closing date of the transaction was September 29, 2009 (the “Closing Date”) and resulted in the ~~amount~~acquisition of OI ~~$48~~(the “Acquisition”). Pursuant to the terms of the Share Exchange Agreement,~~637~~ we acquired all of the outstanding capital stock of OI from ~~inception~~the tofive ~~date. We~~OI ~~have~~shareholders ~~not~~for ~~incurred~~an ~~any~~aggregate ~~other~~of ~~research~~33,050,000 shares, or ~~development~~82.6% ~~expenditures~~of ~~since~~the ~~our~~Company’s ~~incorporation~~common stock.

~~Subsidiaries~~OI was founded in 1997 and until January 2007, was a subsidiary of Coronado Industries, Inc., a publicly traded company. In January 2007, OI was acquired by G. Richard Smith, OI’s President and majority shareholder and former Chairman, Director and principal shareholder of Coronado Industries, Inc. Since January 2007, OI has operated as a private company. At one time OI attempted a merger with a public company, but the terms were unsatisfactory so the deal was not consummated and OI remained private.

WeAs doa ~~not~~result ~~have~~of ~~any~~the ~~subsidiaries~~Share Exchange Agreement, the OI shareholders transferred all their interest in OI to the Company and, as a result, OI became our wholly owned subsidiary.

~~Patents~~Following ~~and~~the ~~Trademarks~~consummation of the Share Exchange Agreement, the Company adopted a fiscal year end of June 30.

WeAs doa ~~not~~further ~~own~~condition of the Share Exchange Agreement, ~~either~~the ~~legally~~current orofficer ~~beneficially~~of the Company resigned and G. Richard Smith was appointed President, ~~any~~Chief ~~patents~~Executive orOfficer ~~trademarks~~and a director of the Company, Gary R. Smith as Chief Financial Officer, Treasurer and Secretary, John Sharkey as a director and Victor Webb as a director.

~~Item 1A. RISK FACTORS~~5

InTable ~~addition~~of ~~to the other information in this current report, the following factors should be carefully considered in evaluating our business and prospects:~~Contents

IFIndex WEto DOFinancial ~~NOT OBTAIN ADDITIONAL FINANCING, OUR BUSINESS WILL FAIL.~~Statements

~~Our~~Prior ~~current~~to ~~operating~~the ~~funds are less than necessary~~Acquisition, ~~and~~G. ~~therefore~~Richard weSmith ~~will~~owned ~~need~~85% ~~to obtain additional financing in order to complete our business plan. As~~ of ~~March 31, 2009, we had cash in~~ the ~~amount~~issued ~~of $117. We currently do not have any operations~~ and weoutstanding ~~have~~capital nostock ~~income. As~~of ~~well, as the lease terms voided with respect to the property, we do not have an interest in any asset~~OI.

~~Our~~The ~~business~~Share ~~plan~~Exchange ~~for~~Agreement ~~the~~contained ~~next~~customary ~~twelve~~terms ~~months~~and ~~calls~~conditions for ~~expenses~~a intransaction ~~connection~~of ~~with~~this ~~the~~type, ~~activities~~including inrepresentations, ~~investigating~~warranties ~~projects~~ and ~~potential~~covenants, ~~acquisition~~as ~~opportunities.~~well Inas ~~addition,~~provisions wedescribing ~~anticipate~~the ~~incurring~~consideration ~~$18~~for the Acquisition,~~000~~ inthe ~~professional~~process ~~fees~~of exchanging the consideration and ~~$11,000~~the ineffect ~~administrative~~of ~~expenses.~~the acquisition.

5Change in Shell Company Status

WeAs will require additional financing in order to meet the anticipated costs and to sustain our business operations. We do not currently have any arrangements for financing and we can provide no assurance to investors that we will be able to find such financing if required. Obtaining additional financing would be subject to a ~~number~~result of ~~factors, including~~ the ~~market~~Share ~~prices for gold~~Exchange, ~~copper,~~we ~~nickel~~ceased ~~and~~being ~~platinum~~a ~~group~~shell ~~metals,~~company ~~investor~~as ~~acceptance~~ of ~~our~~September ~~property and investor sentiment. These factors may make the timing~~29, ~~amount, terms or conditions of additional financing unavailable to us~~2009.

~~The~~Ophthalmic ~~most~~International, ~~likely source of future funds presently available to us is through the sale of equity capital~~Inc. ~~Any sale of share capital will result in dilution to existing shareholders.~~

WESince ~~MAY~~1997, ~~NOT~~Ophthalmic BEInternational, ~~ABLE~~Inc. TOhas ~~OPERATE~~manufactured ASand Amarketed ~~GOING~~a ~~CONCERN~~fixation ~~AND~~device ~~OUR~~with ~~BUSINESS~~a ~~MAY~~patented ~~FAIL~~designed suction ring that treats Open Angle and Pigmentary glaucoma.

~~The~~In ~~Independent~~the ~~Auditor's~~United ~~Report~~States, toglaucoma ~~our~~is ~~audited~~the ~~financial~~second ~~statements~~leading ~~for~~cause ~~the~~of ~~year~~blindness ~~ended~~affecting ~~March~~approximately 313, ~~2009~~000,000 ~~indicates~~persons. ~~that~~Of ~~there~~those, about 60,000 are alegally ~~number~~blind. ofIf ~~factors~~detected ~~that~~and ~~raise~~treated ~~substantial~~early, ~~doubt~~glaucoma ~~about~~need ~~our~~not ~~ability~~cause toblindness ~~continue~~or aseven asevere ~~going~~vision ~~concern~~loss. ~~Such~~ ~~factors~~While ~~identified~~there inis ~~the~~no ~~report~~cure ~~are: at~~for ~~March 31~~glaucoma, ~~2009,~~we believe ~~the~~that ~~Company~~our ~~had~~patented ~~not~~device ~~yet~~and ~~achieved~~process ~~profitable~~provide ~~operations,~~an ~~has~~effective ~~accumulated~~treatment ~~losses~~for ofafflicted ~~$259,506~~persons ~~since~~and ~~its~~that ~~inception,~~a ~~has~~significant aglobal ~~working~~market ~~capital~~for ~~deficiency~~our ofpatented ~~$160~~process,~~232~~ equipment and ~~expects~~rings tocurrently ~~incur~~exists. ~~further~~OI ~~losses~~has innot ~~the~~yet ~~development~~received FDA approval for sale of its ~~business~~products Ifin wethe ~~are~~United ~~not~~States ~~able~~and toat ~~continue~~this astime ait ~~going~~appears ~~concern,~~OI’s itsales isin ~~likely~~Europe ~~investors~~and Canada will ~~lose~~be ~~their~~negatively ~~investments~~impacted until such FDA approval is obtained.

~~BECAUSE~~Glaucoma OFmay ~~THE~~have ~~SPECULATIVE~~many ~~NATURE~~forms OFwhich ~~EXPLORATION~~cause OFor ~~MINERAL~~present ~~PROPERTIES~~a feature of progressive damage to the optic nerve due to increased pressure within the eyeball. As the optic nerve deteriorates, ~~THERE~~blind ISspots Aand ~~SUBSTANTIAL~~patterns ~~RISK~~develop. ~~THAT~~If ~~OUR~~left ~~BUSINESS~~untreated, ~~WILL~~the ~~FAIL~~result may be total blindness. The space between the lens and the cornea in the eye is filled with a fluid called the aqueous humor. This fluid circulates from behind the colored portion of the eye (the iris) through the opening at the center of the eye (pupil) and into the space between the iris and cornea. The aqueous humor is produced constantly, so it must be drained constantly. The drain is at the point where the iris and cornea meet, known as the drainage angle, which directs fluid into a channel (Schlemm’s canal) that then leads it to a system of small veins outside the eye. When the drainage angle does not function properly, the fluid cannot drain and pressure builds up within the eye. Pressure also is exerted on another fluid in the eye, the vitreous humor behind the lens, which in turn presses on the retina. This pressure affects the fibers of the optic nerve, slowly damaging them. The result over time is a loss of vision.

The ~~search~~Fixation for valuable minerals as a business is extremely risky. We can provide investors with no assurance that the mineral property that we will acquire contains commercially exploitable reserves of copper, nickel, gold and platinum group metals. Exploration for minerals is a speculative venture necessarily involving substantial risk. The expenditures to be made by us in the exploration of the optioned mineral properties may not result in the discovery of commercial quantities of minerals. Problems such as unusual or unexpected formations and other conditions are involved in mineral exploration and often result in unsuccessful exploration efforts. In such a case, we would be unable to complete our business plan.Device

~~FLUCTUATIONS~~After INfour ~~COMMODITY~~years ~~PRICE~~of ~~WILL~~ongoing ~~LIKELY~~studies ~~CONTINUE~~involving TODr. ~~ADVERSELY~~John ~~IMPACT~~T. ~~THE~~LiVecchi, ~~COMPANY~~M.D., F.A.C.S., then Assistant Clinical Professor of Ophthalmology, Allegheny University and Dr. Guillermo Avolos, Professor of Ophthalmology, University of Guadalajara, Mexico, it was determined that a 2 minute treatment with Ophthalmic International’s “vacuum fixation device and patented design suction ring” temporarily reduced inter-ocular pressure (“I.O.P.”) in the treatment of Open Angle Glaucoma by approximately 6 Hg for an average of three months at which time the treatment can be repeated with no serious side effects. This I.O.P. lowering is achieved when the external suction device is applied over the perilimbal area for a specified time. With this treatment the Registrant believes that there are no harmful side effects, like those associated with eye drop treatments. In addition, the patent entitled “Open Angle Glaucoma Treatment Apparatus and Method” has been approved.

The current global credit and economic environment has resulted in significantly mineral prices. Minerals are commodities, and therefore their prices are subject to wide fluctuations in response to relatively minor changes in supply and demand. Historically, the markets for minerals have been volatile. These markets will likely continue to be volatile in the future. Such fluctuations could have a material adverse impact on our revenues, earnings, cash flows, asset values and growth in the future. As a result of difficult market and general economic conditions (which may be long lasting and continue to deepen), there is reduced direct and indirect demand for minerals and these declines, if they do not reverse are expected to a material adverse impact on our future revenues, earnings, cash flows, asset values and growth.6

6Table of Contents

~~BECAUSE~~Index OFto ~~THE~~Financial ~~INHERENT DANGERS INVOLVED IN MINERAL EXPLORATION, THERE IS A RISK THAT WE MAY INCUR LIABILITY OR DAMAGES AS WE CONDUCT OUR BUSINESS.~~Statements

The ~~search~~first ~~for~~clinical ~~valuable~~study ~~minerals~~of ~~involves~~OI’s ~~numerous~~product ~~hazards~~(the “PNT device”) was conducted on 86 patients over an 8 month period in 1992 by Dr. As aAvolos ~~result~~in Guadalajara, weMexico. ~~may~~The ~~become~~second ~~subject~~clinical tostudy ~~liabilities~~of ~~for~~OI’s ~~such~~product ~~hazards,~~was ~~including~~conducted ~~pollution,~~on ~~cave~~250 patients over a two-~~ins~~year ~~and~~period ~~other~~ending ~~hazards~~in ~~against~~1996 ~~which~~by weDr. ~~cannot~~Avolos ~~insure~~and orDr. ~~against~~LiVecchi. ~~which~~OI weinitiated ~~may~~a ~~elect~~third ~~not~~study toin ~~insure~~September 1997 conducted by Dr. ~~The~~ ~~payment~~Leo ofBores, ~~such~~the ~~Liabilities~~Medical ~~may~~Director ~~have~~of a ~~material~~Scottsdale ~~adverse~~treatment ~~effect~~center. onThis ~~our~~third ~~financial~~study ~~position~~involved approximately 150 patients.

IFOI WEexecuted ~~BECOME~~a ~~SUBJECT~~distribution TOagreement ~~BURDENSOME~~dated ~~GOVERNMENT~~September ~~REGULATION~~9, OR2003, ~~OTHER~~with ~~LEGAL~~EuPharmed ~~UNCERTAINTIES~~s.r.l. of Rome, ~~OUR~~Italy ~~BUSINESS~~(“EuP”) ~~WILL~~which BEgrants ~~NEGATIVELY~~the ~~AFFECTED~~exclusive distribution rights for OI’s PNT products for the country of Italy to EuP for a period of five years (the “Italian Contract”). This agreement provides for monthly minimum purchase quantities commencing in March 2004. That date was postponed until after the Type 2a product classification was received by OI. OI received its Type 2a product classification in July 2004. In 2007, EuP and OI mutually agreed to terminate the Italian Contract and OI entered into a similar distribution agreement with Go Tech Medical Device, s.r.l. (“Go Tech”).

~~The~~OI ~~legal~~executed ~~and~~a ~~regulatory~~distribution ~~environment~~agreement ~~that~~dated ~~pertains~~November to10, ~~the~~2003, ~~exploration~~with Izasa, S.A. of ~~minerals~~Madrid, isSpain ~~uncertain~~(“Izasa”) ~~and~~which ~~may~~grants ~~change.~~the ~~Uncertainty~~exclusive ~~and~~distribution ~~new~~rights ~~regulations~~for ~~could~~OI’s ~~increase~~PNT ~~our~~products ~~costs~~for the country of ~~doing~~Spain ~~business~~to ~~and~~Izasa ~~prevent~~for usa ~~from~~period ~~exploring~~of ~~for~~five ~~mineral~~years ~~deposits~~(the “Spanish Contract”). ~~The~~Izasa ~~growth~~may ofextend ~~demand~~the agreement for ~~minerals~~an ~~may~~additional ~~also~~two beyears ~~significantly~~by ~~slowed.~~agreeing ~~This~~to ~~could~~additional ~~delay~~minimum ~~growth~~purchases. inThis ~~potential~~agreement ~~demand~~provides for ~~and~~annual ~~limit~~minimum ~~our~~purchase ~~ability~~quantities tocommencing ~~generate~~in ~~revenues~~January 2004. In ~~addition~~OI toexecuted ~~new~~another ~~laws~~agreement ~~and~~dated ~~regulations~~December ~~being~~5, ~~adopted~~2003, ~~existing~~with ~~laws~~Izasa ~~may~~which begrants ~~applied~~to Izasa the exclusive distribution rights to ~~mining~~Izasa ~~that~~for ~~have~~the ~~not~~country of Portugal on the same terms as ~~yet~~the ~~been~~Spanish ~~applied. These~~Contract, ~~new~~except ~~laws~~for ~~may~~the ~~increase~~monthly ~~our~~minimum ~~cost~~purchase quantities for Portugal (the “Portuguese Contract”). Izasa was in violation of ~~doing~~the ~~business~~Spanish Contract and the Portuguese Contract during 2005 with respect to the ~~result~~number ~~that~~of ~~our~~units ~~financial~~ordered ~~condition~~by Izasa. OI is considering terminating these contracts with Izasa and ~~operating~~negotiating ~~results~~a ~~may~~distribution becontract ~~harmed~~with another company.

~~BECAUSE~~The ~~OUR~~receipt ~~SOLE~~by ~~DIRECTOR~~OI ~~OWNS~~in ~~64.3%~~2004 OFof ~~OUR~~its ~~OUTSTANDING~~Type ~~COMMON~~2a ~~STOCK~~product classification allows OI to sell its product in any European Union country. Therefore, ~~THEY~~after ~~COULD~~2004, ~~MAKE~~OI ~~AND~~intensified ~~CONTROL~~its ~~CORPORATE~~marketing ~~DECISIONS~~efforts ~~THAT~~in ~~MAY~~Europe BEto ~~DISADVANTAGEOUS~~increase TOforeign ~~MINORITY~~market ~~SHAREHOLDERS~~sales.

~~Our~~On ~~sole~~April ~~director~~21, ~~owns~~2006, ~~approximately~~OI ~~64.3%~~entered ofinto ~~the~~an ~~outstanding~~agreement ~~shares~~with ofLaboratories ~~our~~DOLIAGE ~~common~~SAS ~~stock.~~(“LDS”) ~~Accordingly,~~which heappointed ~~will~~LDS ~~have~~as aOI’s ~~significant~~exclusive ~~influence~~partner in ~~determining~~France ~~the~~to ~~outcome~~market ofand ~~all~~distribute ~~corporate~~the ~~transactions~~PNT orequipment ~~other~~and ~~matters,~~rings ~~including~~under ~~mergers,~~an ~~consolidations~~arrangement ~~and~~whereby costs paid for the ~~sale~~products ofand ~~all~~certain orLDS ~~substantially~~marketing ~~all~~and ofadministrative ~~our~~expenses ~~assets,~~are ~~and~~charged ~~also~~against ~~the~~sales ~~power~~proceeds, towith ~~prevent~~OI orand ~~cause~~LDS asharing ~~change~~equally in ~~control.~~the ~~The~~net ~~interests~~proceeds. ofOI’s ~~our~~agreement ~~director~~with ~~may~~LDS ~~differ~~has ~~from~~an ~~the~~initial ~~interests~~term of ~~the~~8 ~~other~~years, ~~stockholders~~provided ~~and~~an ~~thus~~annual ~~result~~budget infor ~~corporate~~each ~~decisions~~subsequent ~~that~~year ~~are~~is ~~disadvantageous~~agreed toupon ~~other~~by ~~shareholders.~~the ~~Because~~parties ~~our~~by ~~president~~December ~~has~~31. ~~other~~OI ~~business~~and ~~interests,~~LDS hedid ~~may~~ not beagree ~~able or willing~~ to ~~devote~~an aannual ~~sufficient~~budget ~~amount~~for of2007 ~~time~~by toDecember ~~our~~31, ~~business~~2006. ~~operations~~Therefore, ~~causing~~either ~~our~~party ~~business~~may tonow ~~fail~~terminate this agreement.

~~BECAUSE~~In ~~OUR~~2008, ~~PRESIDENT~~OI ~~HAS~~entered ~~OTHER~~into ~~BUSINESS~~distribution ~~INTERESTS,~~agreements HEfor ~~MAY~~the ~~NOT~~countries BEof ~~ABLE~~Bulgaria, ORCroatia ~~WILLING~~and TOMacedonia ~~DEVOTE~~with AIPSAF ~~SUFFICIENT~~of ~~AMOUNT~~Sofia, OFBulgaria ~~TIME~~and TOfor ~~OUR~~Poland ~~BUSINESS~~with ~~OPERATIONS~~Pharm Supply of Warsaw, ~~CAUSING~~Poland. These ~~OUR~~agreements ~~BUSINESS~~have TOterms ~~FAIL~~similar to the distribution agreement with Go Tech.

~~Our~~During ~~president,~~the ~~Mr.~~fiscal ~~Theodore~~year ~~Tsagkaris~~ending isJune ~~presently~~30, ~~required~~2009, toOI ~~spend~~ only ~~25%~~sold ofproduct ~~his~~under ~~business~~the ~~time~~Go onTech ~~business~~and ~~management~~the ~~services~~LDS ~~for~~distribution ~~our company~~agreements. Under ~~While Mr. Tsagkaris presently possesses adequate time to attend to our interests, it is possible that~~ the ~~demands on Mr. Tsagkaris from his~~ other ~~obligations~~distribution ~~could~~agreements ~~increase with~~ the ~~result~~distributor ~~that~~is hewaiting ~~would~~for nothe ~~longer~~local begovernment ~~able~~ to ~~devote~~approve ~~sufficient time to~~ the ~~management~~product offor ~~our~~use ~~business. In~~in ~~addition,~~the ~~Mr.~~national ~~Tsagkaris~~health ~~may~~care ~~not~~system ~~possess~~or ~~sufficient time~~ for ~~our~~national ~~business~~health ifcare ~~the~~to ~~demands~~approve ofreimbursement ~~managing~~to ~~our~~private ~~business increased substantially beyond current levels~~physicians.

~~IF A MARKET FOR OUR COMMON STOCK DOES NOT DEVELOP, SHAREHOLDERS MAY BE UNABLE TO SELL THEIR SHARES.~~7

~~There~~Table ~~is currently no market for our common stock and we can provide no assurance that a market will develop. We expect to apply for listing~~ of our common stock on the over the counter bulletin board. However, we can provide investors with no assurance that our shares will be traded on the bulletin board or, if traded, that a public market will materialize. If no market is ever developed for our shares, it will be difficult for shareholders to sell their stock. In such a case, shareholders may find that they are unable to achieve benefits from their investment.Contents

7Index to Financial Statements

IFIn A2006, ~~MARKET~~we ~~FOR~~entered ~~OUR~~into ~~COMMON~~an ~~STOCK~~agreement ~~DEVELOPS~~with Beijing Vision World Trading Co. ("BVW") which appointed BVW as the exclusive distributor of our PNT product in China. After four (4) years of effort, ~~OUR~~BVW ~~STOCK~~received ~~PRICE~~approval ~~MAY~~to BEmarket ~~VOLATILE~~our PNT product in China in January 2010. BVW ordered and was delivered 75 PNT units and over 10,000 PNT rings in fiscal 2010.

IfIn aJune ~~market~~2010, ~~for~~we ~~our~~entered ~~common~~into ~~stock~~an ~~develops,~~agreement wewith ~~anticipate~~New ~~that~~Amsterdam Marketing ("NAM") which appointed NAM the ~~market~~exclusive ~~price~~distributor of our ~~common~~PNT ~~stock~~product ~~will~~in beIndia. ~~subject~~This toagreement ~~wide~~with ~~fluctuations~~NAM inhas ~~response~~a toduration ~~several~~of ~~factors,~~five ~~including:~~(5) years and the required annual minimum purchases by NAM total $4 Million US during the term of the agreement.

In August 2010, we entered into an agreement with Ameco Medical Equipment LLC (1"AME") ~~actual~~ orwhich ~~anticipated~~appointed ~~variations~~AME inthe exclusive distributor of our ~~results~~PNT product in Iran, United Arab Emirates and Azerbaijan. This agreement with AME has a duration of ~~operations;~~five (5) years and the required annual minimum purchases by AME total over $6.5 Million US during the term of the agreement.

~~(2) our~~OI’s ~~ability~~vacuum orequipment ~~inability~~is tocomposed ~~generate~~of ~~new~~special ~~revenues;~~order parts, such as the molded case, display board, circuit boards, and motors, all for which OI has established manufacturing relationships with manufacturers. OI assembles the vacuum fixation device at its offices in Fountain Hills, Arizona. OI purchased the patented rings on a purchase-order basis from a medical device manufacturer, which manufactured the rings from the specially designed mold owned by OI.

~~(3) increased~~Governmental ~~competition; and~~Regulation

No medical device may be sold or distributed in the United States without FDA approval or an exemption from such approval. The FDA has the authority to enjoin the manufacture and sale of a medical device, to seize such device and to levy fines against a manufacturer or seller of a medical device which has not been registered or approved for sale in the United States. A device which needs FDA approval is considered a Class III device, unless a similar product with a similar intended use has previously been granted FDA approval (4a “Class II Device”) ~~conditions~~ or the FDA has listed the product as generally safe and ~~trends~~not inneeding FDA approval (a “Class I Device”). The process for having the ~~mineral~~FDA ~~exploration~~remove ~~industry;~~a device from the Class III category to a Class II category is called a 510(k) application.

Coronado Industries, Inc., OI’s parent (5“Coronado”) ~~fluctuations~~, submitted a 510(k) premarket notification to the FDA on its PNT product in ~~commodity~~August ~~prices~~1998. The FDA rejected this notification in October 1998, on the basis that the PNT product was not substantially equivalent to other products currently on the market and intended to lower intraocular pressure. Coronado met with the FDA in February 1999 to discuss the concerns expressed by the agency with respect to the substantial equivalence and safety of the PNT product. Coronado made a submission to the FDA in April 1999 that was intended to provide the agency with detailed information addressing many of the concerns expressed by the FDA at the February 1999 meeting. This submission did not satisfy the FDA with respect to the patient risk associated with the clinical use of the PNT product.

~~Further~~In February 1999, ifthe ~~our~~FDA ~~common~~requested ~~stock~~more isinformation ~~traded~~be submitted on ~~the~~patients ~~NASD~~treated ~~over~~to ~~the~~date ~~counter~~with ~~bulletin~~the ~~board,~~PNT ~~our~~product. ~~stock~~In ~~price~~September ~~may~~1999, bethe ~~impacted~~FDA bydemanded ~~factors~~Coronado ~~that~~submit ~~are~~a ~~unrelated~~new orclinical ~~disproportionate~~protocol tofor ~~our~~additional ~~operating~~patient ~~performance~~studies. ~~These~~ ~~market~~Throughout ~~fluctuations~~2006, asCoronado ~~well~~continued asnegotiation ~~general~~with ~~economic,~~the ~~political~~FDA concerning various features of the protocol and ~~market~~the ~~conditions~~study, such as ~~recessions~~the length of the study and the number of patients, ~~interest~~in ~~rates~~hopes orof ~~international~~expediting ~~currency~~FDA ~~fluctuations~~approval. In ~~may~~2006, ~~adversely~~the ~~affect~~FDA informally advised Coronado that Coronado would need a clinical patient study involving at least 300 patients using the ~~market~~PNT ~~price~~product in the U.S. for at least one year in order to receive FDA approval. However, the protocols for that U.S. patient study would only be approved after an independent clinical patient study of ~~our~~six ~~common~~months ~~stock~~had been submitted to the FDA. All previous patient studies submitted to the FDA had been company monitored.

~~Forward-Looking Statements~~8

~~Certain~~Table statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC. Contents

8Index to Financial Statements

~~ITEM~~At 1Bthe present time, OI is planning on conducting an independent six-month patient study in Canada, and then submitting protocols to the FDA for a one-year U.S. ~~UNRESOLVED~~patient ~~STAFF~~study. OI ~~COMMENTS~~presently estimates the cost of the independent six-month Canadian study to be approximately $1,500,000 and the cost of the one-year U.S. study to be $5,000,000. OI currently estimates the time required to complete these two patient studies and to receive final FDA approval to be approximately three years. There is no assurance the FDA will ever approve any protocols for a U.S. patient study or that OI’s PNT product will ever receive FDA approval.

~~None~~A Class III device may be approved for sale and distribution in the United States by the FDA pursuant to a Premarket Approval Application (“PMA”). The FDA approves PMAs after a review of the clinical trials information contained therein demonstrating that the device is safe and effective for its labeled indications. In addition, the FDA will inspect the facilities where the device is manufactured prior to approving a PMA.

~~ITEM~~Clinical data to support either a 510(k) premarket notification or a PMA must be collected pursuant to the FDA’s Investigational Device Exemption (“IDE”) regulation. The IDE regulation describes two types of device studies: (1) significant risk and (2) nonsignificant risk studies. ~~PROPERTIES~~The principal difference from a regulatory point of view between the two types of studies is that significant risk studies must be reviewed and approved by both the FDA and an Institutional Review Board (“IRB”) before they may be initiated, while nonsignificant risk studies require only IRB review and approval prior to study initiation. OI believes that its studies of its PNT product are nonsignificant risk in nature. OI therefore conducted several clinical studies of the PNT product after receiving IRB approval in 1994, 1996, and 1998 from three different IRBs. The approximately 170 patients treated at the Scottsdale treatment center from 1997 to 1999 were treated in accordance with the clinical protocols that received IRB approval in 1994 and 1998. No negative adverse reactions have been reported in connection with the use of the PNT device on glaucoma patients for any of the studies conducted. However, as of March 3, 2000, the FDA is maintaining that the PNT product presents “significant risk” to patients and is requiring the additional patient study proceed under “significant risk” criteria.

~~Our~~The ~~executive~~manufacturer ~~office~~of a medical device which is ~~located~~to atbe ~~1029~~distributed ~~Logan~~in ~~Avenue,~~the ~~Toronto,~~United ~~Ontario~~States ~~Canada~~must ~~M4K~~be ~~3E7~~inspected and registered with the FDA. The company which currently manufactures OI’s suction ring and the company which sterilizes and packages this ring are registered as medical device manufacturers with the FDA. OI’s facility was inspected and registered with the FDA as a manufacturer of the predecessor fixation device product and the PNT product in 1996.

~~Our~~No ~~officers~~medical ~~provide~~device ~~principal~~may ~~executive~~be ~~office~~advertised ~~space~~for sale in the United States with a false or misleading label or advertisement. The fixation device which preceded the PNT product device was advertised, used and ~~telephone~~sold ~~service~~as ~~free~~a device for certain types of ~~charge~~invasive eye surgeries. ~~The~~ ~~costs~~Therefore, ~~associated~~that ~~with~~product was labeled as only being used for eye surgery, and not the ~~use~~treatment of glaucoma. The labeling of the ~~telephone~~PNT ~~and~~product ~~mailing~~as ~~address~~a ~~were~~glaucoma ~~deemed~~treatment device or a device for the lowering of inter-ocular pressure of glaucoma patients must be approved by ~~management~~the toFDA (or the product must be ~~immaterial.~~exempt from FDA registration as a Class I or Class II device), for OI to advertise and sell its PNT device as a glaucoma treatment product in the United States.

~~ITEM 3. LEGAL PROCEEDINGS~~Patent

~~There~~On ~~are~~February no11, ~~legal~~1997, ~~proceedings~~the ~~pending~~U.S. orPatents ~~threatened~~and ~~against~~Trademarks usOffice issued a seventeen-year patent to Ophthalmic International, L.L.C., another subsidiary of Coronado, Patent Number 5,601,548, for the process, equipment and the procedure. In 2007, this patent was transferred from Ophthalmic International, L.L.C. to OI. OI believes, without assurance, that this patent provided OI with a substantial competitive advantage over current glaucoma treatment competitors. OI is not aware of any other patent being granted for glaucoma treatment.

~~ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS~~9

NoTable ~~matter was submitted during our fiscal year to a vote~~ of ~~security holders, through the solicitation of proxies or otherwise.~~Contents

~~PART~~Index IIto Financial Statements

~~ITEM~~OI 5.follows ~~MARKET~~a ~~FOR~~policy ~~REGISTRANT’S~~of ~~COMMON~~aggressively ~~EQUITY~~pursuing claims of infringement on its patent and OI does not believe its patent, ~~RELATED~~or ~~STOCKHOLDER~~product ~~MATTERS~~or ~~AND~~services ~~ISSUER~~infringed ~~PURCHASES~~on OFthe ~~EQUITY~~rights ~~SECURITIES~~of any other person.

~~Market Information~~Competition

~~Our~~The ~~shares~~medical ofdevice ~~common~~and ~~stock~~service doindustries ~~not~~are ~~trade~~highly oncompetitive. ~~any~~OI’s ~~stock~~patented ~~exchange~~device orand ~~through~~treatment ~~the~~process ~~facilities~~are ofin ~~any~~competition ~~quotation~~with ~~system~~established and future glaucoma treatment procedures and products. ~~While~~ weSince ~~intend~~Medicare todoes ~~apply~~not tocurrently ~~have~~reimburse ~~our~~patients ~~shares~~for the cost of ~~common~~these ~~stock~~prescription ~~quoted~~medications onbut has paid for the ~~National~~PNT ~~Association~~procedure in the past, OI believes a substantial number of ~~Securities~~the ~~Dealers’~~glaucoma ~~OTC~~patients ~~Bulletin~~in ~~Board,~~the ~~there~~U.S. iswould nobenefit ~~guarantee~~economically ~~that~~from wethe ~~will~~PNT procedure to the extent their prescription medication could be ~~successful~~reduced.

~~We have 31 shareholders of record as at the date of this annual report.~~Employees

~~Dividends~~In addition to G. Richard Smith, OI’s sole officer and director, during 2009 and 2008, OI engaged one person as a full-time consultant. OI may hire additional consultants and/or employees in the future.

~~There~~ITEM ~~are no restrictions in our articles of incorporation or bylaws that prevent us from declaring dividends~~1A. ~~The~~RISK ~~Nevada Revised Statutes, however, do prohibit us from declaring dividends where, after giving effect to the distribution of the dividend:~~FACTORS

1Not applicable.

weITEM ~~would~~1B. ~~not~~UNRESOLVED beSTAFF ~~able to pay our debts as they become due in the usual course of business; or~~COMMENTS

2Not applicable.

~~our~~ITEM total assets would be less than the sum of our total liabilities plus the amount that would be needed to satisfy the rights of shareholders who have preferential rights superior to those receiving the distribution2. PROPERTIES

WeCoronado, ~~have~~OI’s ~~not~~former ~~declared~~parent, entered ~~any~~into ~~dividends~~a five-year lease for approximately 3,500 ~~and~~square wefeet doof ~~not~~space ~~plan~~at toa ~~declare~~monthly ~~any~~rent ~~dividends~~of in$4,520 commencing on December 1, 2004. In January 2007, as part of the ~~foreseeable~~sale ~~future~~of OI to Mr. Smith, this lease was assigned to him. OI’s address is 16857 E. Saguaro Boulevard, Fountain Hills, Arizona 85268.

9ITEM 3. LEGAL PROCEEDINGS

~~ITEM~~In 6January 2010, we commenced negotiations with certain creditors for the repayment of their entire debt during 2010, based upon expected financing during 2010. ~~SELECTED~~There ~~FINANCIAL~~is ~~DATA~~no assurance our efforts to negotiate with our creditors will be resolved without litigation.

~~The~~On December ~~registrant~~16, is2009, our patent attorneys, Meschkow & Gresham, P.L.C., filed a ~~smaller~~lawsuit ~~reporting~~(CV ~~company~~2009-037698) in the Superior Court for Maricopa County, Arizona against the Company and isMr. Richard Smith for breach of contract in the failure to pay for legal services in the amount of $12,063 plus costs and legal fees. Our answer to the complaint admitted that legal services had been provided but claimed no knowledge of the value of those services. This case was transferred to arbitration and an award was rendered in the amount of $8,064 against G. Richard Smith, our President and Director, his wife, Karen Smith and the Ophthalmic International, Inc., our wholly-owned subsidiary, plus court costs of $453 and attorney fees of $1,500. This arbitration award has not ~~required~~been filed with the Clerk of the Court to ~~provide~~proceed ~~this~~to ~~information~~judgment yet.

~~ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS~~10

~~Plan~~Table of ~~Operation~~Contents

~~Our~~Index ~~plan of operation for the twelve months following the date of this report is~~ to ~~investigate~~Financial ~~projects and potential acquisition opportunities. However, no tentative project or acquisition opportunities have been considered yet.~~Statements

InDuring ~~addition~~our fourth quarter 2010, weCharles ~~anticipate~~E. ~~spending~~Brokup filed a lawsuit (CV 2010-054295) in Superior Court for Maricopa County, Arizona against Ophthalmic International, Inc. and Mr. G. Richard Smith for breach of promise to pay $1810,000 principal on ~~professional~~a ~~fees~~promissory note and $111,000 onper ~~administrative~~month ~~expenses~~in interest. Our answer to the complaint admitted that the principal amount of $10,000 was owed but denies that more than legal interest is owed after the first month expressly stated interest of $1,000.

~~Excluding~~Subsequent any possible mineral property payments and exploration costs, total expenditures over the next 12 months are therefore expected to be $29,000. Our cash on hand at March 31, 2009 was $117. Accordingly, we will need to raise additional funds in order to meet our expected expenses. We do not currently have any arrangements for raising additional funding, except for getting advances from the sole directorEvent

~~The~~During ~~Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain~~ the ~~necessary~~first ~~financing~~quarter toin ~~meet~~our ~~its~~2011 ~~obligations~~fiscal ~~and~~year, ~~repay~~Francesco ~~its~~Aspes, ~~liabilities~~our ~~arising~~former ~~from~~European ~~normal~~marketing ~~business~~consultant, ~~operations~~filed ~~when~~a ~~they~~lawsuit ~~come~~(CV ~~due. Management~~2010-028530) ~~has no formal plan~~ in ~~place~~the toSuperior ~~address~~Court ~~this~~for ~~concern~~Maricopa ~~but~~County, ~~considers~~Arizona ~~that~~against the Company ~~will~~for befailure ~~able~~ to ~~obtain~~pay ~~additional~~him ~~funds~~$180,000 byof ~~equity~~employee ~~financing~~wages ~~and/or~~earned ~~related~~previously ~~party~~plus ~~advances~~80,000 ~~however~~Euros ~~there~~of isexpenses noincurred ~~assurance~~as an employee of ~~additional~~the ~~funding~~Company. ~~being~~Our ~~available~~answer orto onthis ~~acceptable~~complaint ~~terms,~~has ifnot atyet ~~all~~been filed.

~~Results~~Other ofthan ~~Operations~~as ~~for~~set ~~Year~~forth ~~Ending~~above, ~~March~~the ~~31,~~Company ~~2009~~is not currently a party to any pending lawsuit or legal proceeding.

WeITEM ~~incurred a net loss of $29,051 for the year-ended March 31, 2009, as compared to a loss of $40,603 in the same period in 2008~~4. ~~The~~ ~~decrease in net loss was primarily due to the decrease in transfer agent and filing fees. The president charges the Company $500 per month on a month by month basis~~ (~~total~~REMOVED ~~management~~AND ~~fee charged: 2009 - $6,000; 2008 - $6,000~~RESERVED). The Company incurred $50 for miscellaneous office expenses (2008 - $121). Our liabilities at the same date totalled $160,349 and consisted of accounts payable of $35,006, advances payable of $5,300, and $120,043 due to our president.

~~ITEM~~Not 7Aapplicable. ~~QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK~~

~~Not required.~~11

~~ITEM~~Table ~~8: FINANCIAL~~of ~~STATEMENTS AND SUPPLEMENTARY DATA~~Contents

10Index to Financial Statements

~~TARI~~PART ~~INC.~~II

(AITEM ~~Pre-exploration~~5. ~~Stage~~MARKET ~~Company)~~FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES

~~REPORT~~Market ~~AND FINANCIAL STATEMENTS~~Information

~~MARCH~~The 31Company’s common stock is traded in the over-the-counter market and is quoted on the “FINRA OTC Bulletin Board” under the symbol “SNDZ.OB.” Our shares of common stock did not begin trading until October, 2009. The ~~AND~~table ~~2008~~below sets forth, for the calendar quarters indicated, the high and low selling prices for the SunRidge common stock as reported by the NASDAQ.com. These quotations may represent prices between dealers without adjustment for retail markups, markdowns or commissions and may not represent actual transactions.

(Stated in US Dollars)

	Selling Price
Quarter Ended	High		Low

December 31, 2009	$	1.13	$	1.05
March 31, 2010	$	2.00	$	.35
June 30, 2010	$	0.49	$	0.21

11Authorized Capital

	BDO Dunwoody LLP	600 Cathedral Place
	Chartered Accountants	925 West Georgia Street
		Vancouver, BC, Canada V6C 3L2
		Telephone: (604) 688-5421
		Telefax: (604) 688-5132
		E-mail: vancouver@bdo.ca
		www.bdo.ca

As of June 30, 2010, our authorized capital stock consists of 550,000,000 shares of common stock, $0.001 par value, and 50,000,000 shares of preferred stock, $0.001 par value.

~~REPORT~~Common ~~OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM~~Stock

ToSubject to preferences that may apply to shares of preferred stock outstanding at the ~~Stockholders~~time, the holders of outstanding shares of Common Stock are entitled to receive dividends out of assets legally available at times and in amounts as our Board of Directors may determine. Each stockholder is entitled to one vote for each share of Common Stock held on all matters submitted to a vote of the stockholders.

~~Tari~~Cumulative ~~Inc~~voting is not provided for in our articles of incorporation or any amendments thereto, which means that the majority of the shares voted can elect all of the directors then standing for election. The Common Stock is not entitled to preemptive rights and is not subject to conversion or redemption. Upon the occurrence of a liquidation, dissolution or winding-up, the holders of shares of Common Stock are entitled to share ratably in all assets remaining after payment of liabilities and satisfaction of preferential rights of any outstanding preferred stock. There are no sinking fund provisions applicable to the Common Stock. The outstanding shares of Common Stock are, and the shares of Common Stock to be issued upon conversion of the Warrants will be, fully paid and non-assessable.

~~(A Pre-exploration Stage Company)~~12

WeTable ~~have audited the accompanying balance sheets~~ of Tari Inc. (the “Company”) (A Pre-exploration Stage Company) as of March 31, 2009 and 2008 and the related statements of operations, cash flows and stockholders' equity (deficiency) for the years then ended and for the period from the inception of the development stage, May 2, 2001 to March 31, 2009. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. Contents

WeIndex ~~conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit~~ to ~~obtain~~Financial reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. Statements

InPreferred our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Tari Inc. as of March 31, 2009 and 2008 and the results of its operations and its cash flows for the years then ended and for the period from inception of the development stage May 2, 2001 to March 31, 2009, in conformity with accounting principles generally accepted in the United States of America.Stock

The ~~accompanying~~Company’s ~~financial~~Board ~~statements~~of ~~referred~~Directors tohas ~~above~~the ~~have~~authority ~~been~~to ~~prepared~~divide ~~assuming that~~ the ~~Company~~preferred ~~will~~stock ~~continue~~shares asinto aseries ~~going~~and ~~concern. As discussed in Note 1~~ to fix the ~~financial~~voting ~~statements~~powers, ~~the~~designation, ~~Company is in the pre-exploration stage~~preference, ~~has not yet achieved profitable operations~~ and isrelative ~~dependent~~participating, onoption ~~its ability to raise capital from shareholders~~ or other ~~sources~~special torights, ~~meet its obligations~~ and ~~repay~~the ~~its liabilities arising from normal business operations when they come due. These factors~~qualifications, ~~along with other matters as set forth in Note 1~~limitations, ~~raise~~or ~~substantial~~restrictions ~~doubt~~of ~~that~~ the ~~Company~~shares ~~will~~of beany ~~able~~series toso ~~continue as a going concern~~established. The ~~financial~~Company ~~statements~~has doissued ~~not~~no ~~include~~preferred ~~any~~stock ~~adjustments~~shares ~~that~~as ~~might result from the outcome~~ of ~~these~~November ~~uncertainties.~~11, 2010.

~~/s/ BDO Dunwoody LLP~~Stockholders

~~Chartered~~On ~~Accountants~~November ~~Vancouver~~11, ~~Canada~~2010, ~~June~~there ~~19,~~were ~~2009~~approximately 35 holders of record of the Company’s common stock. Such record holders do not include individual participants in nominee name listings.

~~BDO~~Transfer ~~Dunwoody~~Agent ~~LLP~~and ~~is a Limited Liability Partnership registered in Ontario~~Registrar

12Quicksilver Stock Transfer is currently the transfer agent and registrar for our Common Stock. Its address is 6623 Las Vegas Blvd Suite 255, Las Vegas, Nevada 89119. Its phone number is (702) 629-1883 and its fax number is (702) 562-9791.

~~TARI INC.~~ Dividends

(AThe ~~Pre-exploration~~Company ~~Stage~~has not paid cash dividends on its common stock since organization. For the foreseeable future, the Company) expects that earnings, if any, will be retained for use in the business or be used to retire obligations of the Company.

~~BALANCE~~Sale ~~SHEETS~~of Unregistered Equity Securities

~~March~~During 31the quarter ended June 30, ~~2009~~2010, the Company issued the following shares of restricted common stock: (i) 48,234 shares for $12,450 of services by one Non-Accredited Investor, as defined by SEC Rule 501; (ii) 772,811 shares in conversion of $205,310 of debt and ~~2008~~accrued interest and fees by eight Non-Accredited Investors; and (iii) 76,667 shares for $21,800 of consulting services by two Non-Accredited Investors. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.

~~(Stated~~Subsequent ~~in US Dollars)~~Events

ASSETS
		2009			2008
Current
Cash	$	117		$	709
LIABILITIES
Current
Accounts payable and accrued liabilities – Note 5	$	35,006		$	30,147
Advances payable – Note 4		5,300			5,300
Due to related party – Note 6		120,043			96,443
		160,349			131,890
STOCKHOLDERS’ DEFICIENCY
Preferred stock, $0.001 par value 10,000,000 shares authorized, none outstanding
Common stock, $0.001 par value 100,000,000 shares authorized 3,890,000 (2008: 3,890,000) shares issued		3,890			3,890
Additional paid-in capital		95,384			95,384
Deficit accumulated during the pre-exploration stage		(259,506	)		(230,455	)
		(160,232	)		(131,181	)
	$	117		$	709

Between July 1, 2010 and November 11, 2010, the Company issued the following restricted common stock: (i) 105,578 shares for $16,800 of services by one Non-Accredited Investor, as defined by SEC Rule 501; (ii) 432,058 shares in conversion of $72,750 of debt and accrued interest by six Non-Accredited Investors; (iii) 700,000 shares for $144,000 of public relations services by three Non-Accredited firms; (iv) 890,909 shares to three Non-Accredited Investors for $51,000 cash; and (v) 259,091 shares for $27,500 of consulting services by two Non-Accredited Investors. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.

~~Nature~~ITEM of6. ~~Operations~~SELECTED ~~and~~FINANCIAL ~~Ability to Continue as a Going Concern – Note 1 Subsequent Event – Note 6~~DATA

~~SEE~~Not ~~ACCOMPANYING SUMMARY OF ACCOUNTING POLICIES AND NOTES TO FINANCIAL STATEMENTS~~applicable.

~~TARI~~Table ~~INC.~~of Contents

(AIndex ~~Pre-exploration~~to ~~Stage~~Financial ~~Company)~~Statements

~~STATEMENTS~~ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

~~for~~Fiscal ~~the~~Year ~~years~~Ending ~~ended~~June ~~March 31~~30, ~~2009 and 2008 and~~2010

~~for the period from May 2, 2001 (Date of Inception) to March 31, 2009~~Operations

~~(Stated~~The Company’s revenue in USfiscal ~~Dollars~~year 2010 increased by 71.0% ($61,290) over fiscal year 2009, but total expenses far exceeded our revenues in fiscal year 2010. Our gross margin increased from 66.6% in fiscal year 2009 to 76.4% in fiscal year 2010 as a result of a higher per unit price charged customers in 2010.

								(Cumulative)
								May 2, 2001
								(Date of
		Years ended						Inception) to
		March 31,						March 31,
		2009			2008			2009
Expenses
Audit and accounting fees	$	18,795		$	12,382		$	85,674
Bank charges		210			176			1,599
Consulting fees		-			-			20,500
Interest expenses		-			-			4,774
Legal fees		-			-			31,668
Management fees – Note 5		6,000			6,000			28,500
Mineral lease costs		-			-			48,637
Office expenses		50			121			11,357
Transfer agent and filing fees		3,996			21,924			42,157
Net loss before other item		(29,051	)		(40,603	)		(274,866	)
Other item
Debt forgiven		-			-			15,360
Net loss for the period	$	(29,051	)	$	(40,603	)	$	(259,506	)
Basic and diluted loss per share	$	(0.01	)	$	(0.01	)
Weighted average number of shares outstanding		3,890,000			3,890,000

Our loss from operations increased by 423.6% in fiscal year 2010 in comparison to fiscal year 2009 because of our increased general and administrative expenses. Our total general and administrative expenses increased by 344.8% in the fiscal year ended June 30, 2010 in comparison to the 2009 fiscal year as a result primarily of Reorganization Costs, Loss on Stock Issuance, increased Employee and Consultant Expenses, Legal and Professional Fees, Selling and Marketing Expenses and Rent Expense. The Reorganization Costs of $199,673 were incurred as a result of the Company's acquisition of Ophthalmic International, Inc. in October 2009. The Loss on Stock Issuance of $186,159 occurred as a result of issuing restricted stock at a value less than the market value of free trading stock to induce conversion of debt. Our Employee and Consultants Expenses increased by more than 864.3% in the 2010 fiscal year over the 2009 fiscal year as a result of the hiring of our European consultant in the second quarter of our 2010 fiscal year and hiring a public relations firm in the fourth quarter of the year. Our Employee and Consultant Expenses will likely increase as we expand the shipment of our products to China, Europe and the Caribbean in the future, assuming we can obtain sufficient working capital. We will likely commence paying our officers and Directors compensation some time in the future. Our Legal and Professional Fees increased by 158.0% during the 2010 fiscal year because of the acquisition of Ophthalmic International in October 2009 and the increased legal and accounting expenses incurred as an operating SEC reporting company. Our Selling and Marketing Expenses increased by 112.4% during the 2010 fiscal year over the 2009 fiscal year as a result of our increased marketing activities in India and the Middle East. Our Selling and Marketing Expenses will likely increase as we expand sales of our products to China, Europe and the Caribbean in the future. We are likely to incur additional research and development expenses in fiscal year 2011 if we apply to the FDA for our U.S. clinical study protocols. There is no assurance that we will ever be profitable.

~~SEE~~Liquidity ~~ACCOMPANYING~~and ~~SUMMARY~~Capital ~~OF ACCOUNTING POLICIES AND NOTES TO FINANCIAL STATEMENTS~~Resources

We suffered a severe liquidity shortage in 2009 and 2010. From July 1, 2009 to June 30, 2010, we borrowed a total of $619,711. These loans bear annual interest from 12% and all of the loans are due on demand or prior to June 30, 2011. Our interest expense increased by 25.0% ($14,412) from fiscal year 2009 to fiscal year 2010. Without substantial funding in the near future, our liquidity shortage will become critical. We are hopeful we will be able to obtain substantial funding during the remainder of fiscal year 2011, but we presently have no agreements or arrangements to obtain any such funding. The consolidated financial statements contained in this Form 10-K have been prepared assuming we will continue to operate as a going concern and do not include any adjustments that might be necessary if we are unable to continue as a going concern. As a result, our independent registered public accountants have issued a going concern explanatory paragraph to their audit report on our consolidated financial statements for the fiscal year ended June 30, 2010.

~~TARI INC.~~14

(ATable ~~Pre-exploration~~of ~~Stage Company)~~Contents

~~STATEMENT~~Index OFto ~~STOCKHOLDERS’~~Financial ~~EQUITY (DEFICIENCY)~~Statements

~~for~~Over the ~~period~~next ~~from~~three ~~May 2~~years, ~~2001~~we ~~(Date~~must obtain at least $6,500,000 of ~~Inception)~~funding to ~~March~~finance 31our two planned patient clinical studies in Canada and the US, ~~2009~~and a minimum level of administrative staff. If such funding is not obtained, it is unlikely we will receive FDA approval for the sale of our product in the U.S. Without FDA approval our revenues will be totally dependent on foreign sales.

~~(Stated~~Critical inAccounting ~~US Dollars)~~Policies

							Deficit
							Accumulated
					Additional		During the
	Common Shares				Paid-in		Pre-exploration
	Number		Par Value		Capital		Stage			Total
Capital stock issued for cash – at $0.01	2,500,000	$	2,500	$	22,500	$	-		$	25,000
Net loss for the period ended March 31, 2002	-		-		-		(39,696	)		(39,696	)
Balance, March 31, 2002	2,500,000		2,500		22,500		(39,696	)		(14,696	)
Capital stock subscribed pursuant to an offering memorandum for cash – at $0.05	1,390,000		1,390		68,110		-			69,500
Net loss for the year ended March 31, 2003	-		-		-		(27,653	)		(27,653	)
Balance, March 31, 2003	3,890,000		3,890		90,610		(67,349	)		27,151
Net loss for the year ended March 31, 2004	-		-		-		(17,858	)		(17,858	)
Balance, March 31, 2004	3,890,000		3,890		90,610		(85,207	)		9,293
Net loss for the year ended March 31, 2005	-		-		-		(24,235	)		(24,235	)
Balance, March 31, 2005	3,890,000		3,890		90,610		(109,442	)		(14,942	)
Net loss for the year ended March 31, 2006	-		-		-		(38,388	)		(38,388	)
Balance, March 31, 2006	3,890,000		3,890		90,610		(147,830	)		(53,330	)
Interest contributed	-		-		4,774		-			4,774
Net loss for the year ended March 31, 2007	-		-		-		(42,022	)		(42,022	)
Balance, March 31, 2007	3,890,000		3,890		95,384		(189,852	)		(90,578	)
Net loss for year ended March 31, 2008	-		-		-		(40,603	)		(40,603	)
Balance, March 31, 2008	3,890,000		3,890		95,384		(230,455	)		(131,181	)
Net loss for the year ended March 31, 2009	-		-		-		(29,051	)		(29,051	)
Balance, March 31, 2009	3,890,000	$	3,890	$	95,384	$	(259,506	)	$	(160,232	)

Our critical accounting policies include revenue recognition, allowance for bad debts, income taxes, debt and equity-based transactions, and are discussed in detail in the financial statements filed herewith, as are recent accounting pronouncements.

~~SEE~~ITEM ~~ACCOMPANYING~~7A. ~~SUMMARY~~QUANTITATIVE ~~OF ACCOUNTING POLICIES~~ AND ~~NOTES~~QUALITATIVE TODISCLOSURES ~~FINANCIAL~~ABOUT ~~STATEMENTS~~MARKET RISK

15Not applicable.

~~TARI INC.~~15

(ATable ~~Pre-exploration~~of ~~Stage Company)~~Contents

~~STATEMENTS~~Index OFto ~~CASH~~Financial ~~FLOWS~~Statements

~~for~~ITEM ~~years~~8. ~~ended~~FINANCIAL ~~March~~STATEMENTS ~~31,~~AND ~~2009~~SUPPLEMENTARY ~~and 2008 and~~DATA

~~for~~SUNRIDGE ~~the period from May 2~~INTERNATIONAL, ~~2001 (Date of Inception) to March 31, 2009~~INC.

~~(Stated~~INDEX inTO USCONSOLIDATED ~~Dollars)~~FINANCIAL STATEMENTS

								(Cumulative)
	Page
								May 2,
Report of Independent Registered Public Accounting Firm	17
								2001 (Date of
Consolidated Balance Sheets as of June 30, 2010 and 2009	18
		Years ended						Inception) to
Consolidated Statements of Operations for the Years Ended June 30, 2010 and 2009	19
		March 31						March 31,
Consolidated Statements of Stockholders’ Equity for the Years Ended June 30, 2010 and 2009	20
		2009			2008			2009
Consolidated Statements of Cash Flows for the Years Ended June 30, 2010 and 2009	21
Cash Flows used in Operating Activities
Notes to Consolidated Financial Statements	22
Net loss for the period	$	(29,051	)	$	(40,603	)	$	(259,506	)
Add (deduct) items not involving cash:
Interest expense		-			-			4,774
Debt forgiven		-			-			(15,360	)
Change in non-cash working capital items related to operations:
Accounts payable and accrued liabilities		4,859			(584	)		50,366
		(24,192	)		(41,187	)		(219,726	)
Cash Flows provided by Financing Activities
Proceeds from shares issued		-			-			94,500
Increase in advance payable		-			-			5,300
Due to related party		23,600			39,130			120,043
		23,600			39,130			219,843
Increase (decrease) in cash during the period		(592	)		(2,057	)		117
Cash, beginning of the period		709			2,766			-
Cash, end of the period	$	117		$	709		$	117

~~SEE ACCOMPANYING SUMMARY OF ACCOUNTING POLICIES AND NOTES TO FINANCIAL STATEMENTS~~16

16Table of Contents

~~TARI~~Index ~~INC.~~to Financial Statements

(AREPORT ~~Pre-exploration~~OF ~~Stage~~INDEPENDENT ~~Company)~~REGISTERED PUBLIC ACCOUNTING FIRM

~~NOTES~~Board TOof ~~THE~~Directors ~~FINANCIAL~~and ~~STATEMENTS~~Shareholders

~~March~~Sunridge 31International, ~~2009 and 2008~~Inc.

~~(Stated~~We have audited the accompanying consolidated balance sheets of Sunridge International, Inc. as of June 30, 2010 and 2009, and the related consolidated statements of operations, changes in USshareholders' ~~Dollars)~~equity, and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

~~Note~~We 1conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

~~Nature~~In ofour ~~Operations~~opinion, ~~and~~the ~~Ability~~consolidated financial statements referred to ~~Continue~~above present fairly, in all material respects, the consolidated financial position of Sunridge International, Inc. as aof ~~Going~~June ~~Concern~~30, 2010 and 2009 and the results of its operations, changes in shareholders' equity, and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company iswill continue as a going concern. As discussed in Note 1 to the ~~pre-exploration~~consolidated ~~stage~~financial ~~and~~statements, isthe ~~investigating~~Company ~~projects~~has suffered recurring losses from operations, anticipates additional losses in the next year, and ~~potential~~has ~~acquisition~~insufficient ~~opportunities~~working capital as of June 30, 2010 to ~~acquire~~fund ~~and~~the ~~explore~~anticipated ~~mineral~~losses. ~~properties~~These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~The~~/s/ ~~Company~~Semple, ~~was~~Marchal ~~incorporated~~& ~~in the State of Nevada on May 2~~Cooper, ~~2001 and its fiscal year end is March 31.~~LLP

~~The~~Certified ~~financial~~Public statements have been prepared using generally accepted accounting principles in the United States of America applicable for a going concern which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At March 31, 2009, the Company had not yet achieved profitable operations, has accumulated losses of $259,506 since its inception, has a working capital deficiency of $160,232 and expects to incur further losses in the development of its business, all of which casts substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however there is no assurance of additional funding being available or on acceptable terms, if at all.Accountants

17Phoenix, Arizona

~~Note~~November 215, 2010

~~Summary of Significant Accounting Policies~~17

~~The~~Table ~~financial statements~~ of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates that have been made using careful judgement. Actual results may vary from these estimates.Contents

~~The~~Index ~~financial~~to ~~statements~~Financial ~~have, in management’s opinion, been properly prepared within the framework of the significant accounting policies summarized below:~~Statements

~~Pre-exploration~~SUNRIDGE ~~Stage~~INTERNATIONAL, ~~Company~~INC.

~~The~~CONSOLIDATED ~~Company~~BALANCE ~~complies with Financial Accounting Standard Board Statement No. 7 and the Securities and Exchange Commission Exchange Act Guide 7 for its characterization of the Company as pre-exploration stage.~~SHEETS

~~Mineral~~JUNE ~~Property~~30, ~~Costs~~2010 AND 2009

Mineral property exploration costs are expensed as incurred. Mineral property acquisition costs are initially capitalized when incurred using the guidance in EITF 04-02, “Whether Mineral Rights Are Tangible or Intangible Assets”. The Company assesses the carrying costs for impairment under SFAS 144, “Accounting for Impairment or Disposal of Long Lived Assets” at each fiscal quarter end. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs then incurred to develop such property, are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations.

	6/30/2010			6/30/2009
ASSETS

CURRENT ASSETS
Cash & Cash Equivalents	$	–		$	–
Accounts Receivable		8,927			–
Employee Advances		3,400			–
Prepaids		179,814			–
Inventory		20,920			3,556

Total Current Assets		213,061			3,556

Property and equipment, net		2,871			3,669

OTHER ASSETS
Deposits		–			4,520

TOTAL ASSETS	$	215,932		$	11,745


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES
Notes payable - related parties	$	203,976		$	269,726
Notes payable		293,202			215,300
Accounts payable		307,805			101,452
Cash Overdraft		1,633			2,463
Accrued interest		44,902			61,553

TOTAL LIABILITIES	$	851,518		$	650,494

COMMITMENTS		–			–

Preferred Stock - $0.0001 par value; 50,000,000 shares authorized, none issued or outstanding		–			–
Common Stock - $0.001 par value; 550,000,000 shares authorized 42,942,180 and 40,000,000 shares outstanding at June 30, 2010 and June 30, 2009, respectively		42,942			40,000
Additional paid-in capital		13,407,088			12,386,970
Accumulated deficit		(14,085,616	)		(13,065,719	)

TOTAL STOCKHOLDERS' EQUITY(DEFICIT)		(635,586	)		(638,749	)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY(DEFICIT)	$	215,932		$	11,745

~~Environmental~~The ~~Costs~~accompanying notes are an integral part of these consolidated financial statements.

Environmental expenditures that relate to current operations are expensed or capitalized as appropriate. Expenditures that relate to an existing condition caused by past operations, and which do not contribute to current or future revenue generation, are expensed. Liabilities are recorded when environmental assessments and/or remedial efforts are probable, and the cost can be reasonably estimated. Generally, the timing of these accruals coincides with the earlier of completion of a feasibility study or the Company’s commitments to plan of action based on the then known facts.18

18Table of Contents

~~Note~~Index 2to Financial Statements

~~Summary~~SUNRIDGE ofINTERNATIONAL, ~~Significant Accounting Policies – (cont’d)~~INC.

~~Income~~CONSOLIDATED ~~Taxes~~STATEMENTS OF OPERATIONS

~~The~~FOR ~~Company~~THE ~~uses~~YEARS ~~the~~ENDED ~~assets~~JUNE and liability method of accounting for income taxes pursuant to Statement of Financial Accounting Standards (“SFAS”) No. 109 “Accounting for Income Taxes”. Under the assets and liability method of SFAS No. 10930, ~~deferred~~2010 ~~tax~~AND assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.2009

In June 2006, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes”. The interpretation clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements in accordance with SFAS No. 109, “Accounting for Income Taxes”. Specifically, the pronouncement prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The interpretation also provides guidance on the related derecognition, classification, interest and penalties, accounting for interim periods, disclosure and transition of uncertain tax positions. The interpretation is effective for fiscal years beginning after December 15, 2006. The adoption of FIN 48 did not have a material impact on the Company’s financial position, results of operations or cash flows.

	Year ended June 30,
	2010			2009

PRODUCT REVENUES	$	147,566		$	86,276

Cost of Product Revenues		34,827			28,834

GROSS PROFIT		112,739			57,442

GENERAL & ADMINISTRATIVE EXPENSES
Employee and Consultant Expenses		297,496			30,850
FDA Expenses		2,008			–
Freight		8,415			1,397
Depreciation		798			799
Telephone & Utilities		6,218			10,546
Office Expenses		4,941			26,014
Insurance		21,035			30,726
Travel & Entertainment		9,723			300
Loss on Stock Issuances		186,159			–
Legal and professional fees		164,947			63,931
Reorganization Costs		199,673			–
Bank Service Fees		2,522			213
Auto Expense		5,195			–
Dues & Subscriptions		703			997
Repairs & Maintenance		9,040			–
Rent expense		70,646			54,240
Selling & marketing expenses		36,209			17,045
Other General and Operating Expenses		35,376			1,500

TOTAL GENERAL & ADMINISTRATIVE EXPENSES		1,061,104			238,558

LOSS FROM OPERATIONS		(948,365	)		(181,116	)

OTHER INCOME (EXPENSES)
Other Income		422			1,755
Interest expense		(71,954	)		(57,542	)

TOTAL OTHER INCOME (EXPENSES)		(71,532	)		(55,787	)

NET LOSS	$	(1,019,897	)	$	(236,903	)

Basic and Diluted Loss per Share		(0.03	)		(0.01	)

Weighted Average Shares Outstanding		40,531,829			40,000,000

~~Basic~~The ~~and~~accompanying ~~Diluted~~notes ~~Loss~~are ~~Per~~an ~~Share~~integral part of these consolidated financial statements.

The Company reports basic loss per share in accordance with the SFAS No. 128, “Earnings Per Share”. Basic loss per share is computed using the weighted average number of shares outstanding during the period. Diluted earnings (loss) per share are computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (primarily outstanding options and warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company’s net income (loss) position at the calculation date. Diluted loss per share is the same as basic loss per share in the periods presented as the effects of potential common stock equivalents are anti-diluted.19

~~Financial~~Table ~~Instruments~~of Contents

~~The~~Index ~~carrying value of cash, accounts payable and accrued liabilities, advances payable and due~~ to ~~related~~Financial party approximates fair value because of the short maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.Statements

19SUNRIDGE INTERNATIONAL, INC.

~~Note~~CONSOLIDATED 2STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

~~Summary~~FOR ofTHE ~~Significant~~YEARS ~~Accounting~~ENDED ~~Policies~~JUNE –30, ~~(cont’d)~~2010 AND 2009

Staff Accounting Bulletin No. 108 (“SAB 108”)

	Common Stock						Additional						Stockholders'
							Paid-in			Accumulated			Equity
	Shares			Par Value			Capital			Deficit			(Deficit)

BALANCE AT JULY 1, 2008		19,450,000		$	19,450		$	12,407,520		$	(12,828,816	)	$	(401,846	)

Effect of recapitalization (See Note 1):
Stock Retired		(12,500,000	)		(12,500	)		12,500			–			–

Issuance of Common Stock		33,050,000			33,050			(33,050	)		–			–

BALANCE AT JULY 1, 2008
RECAPITALIZED		40,000,000			40,000			12,386,970			(12,828,816	)		(401,846	)

Net Loss for the year ended June 30, 2009		–			–			–			(236,903	)		(236,903	)

BALANCE AT JUNE 30, 2009		40,000,000		$	40,000		$	12,386,970		$	(13,065,719	)	$	(638,749	)

Common Stock Issued for Services		1,160,855			1,161			327,875			–			329,036

Common Stock Issued for Debt and Interest		1,781,325			1,781			506,084			–			507,865

Loss on Stock Issuances		–			–			186,159			–			186,159

Net Loss for the year ended June 30, 2010		–			–			–			(1,019,897	)		(1,019,897	)

BALANCE AT JUNE 30, 2010		42,942,180			42,942			13,407,088			(14,085,616	)		(635,586	)

InThe ~~September~~accompanying ~~2006,~~notes the SEC issued Staff Accounting Bulletin No. 108 (“SAB 108”). Due to diversity in practice among registrants, SAB 108 expressed SEC staff views regarding the process by which misstatements in financial statements are ~~evaluated~~an ~~for~~integral ~~purposes~~part of ~~determining~~these ~~whether~~consolidated financial ~~statement restatement is necessary~~statements. ~~SAB 108 is effective for fiscal years ending after November 15, 2006. SAB 108 did not have a material impact on the Company’s financial position or results from operations.~~

~~New Accounting Standards~~ 20

~~Recently~~Table ~~adopted~~of ~~accounting pronouncements~~ Contents

InIndex September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements”. This Statement defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosure related to ~~the~~Financial use of fair value measures in financial statements. The Statement is to be partially effective for the Company’s financial statements issued for its fiscal year beginning April 1, 2008. This Statement did not have an impact on the Company’s financial position or results of operations.Statements

OnSUNRIDGE ~~February 15~~INTERNATIONAL, ~~2007, the FASB issued SFAS No~~INC. 159, “The Fair Value Option for Financial Assets and Financial Liabilities”. This Statement establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective for the Company’s financial statements issued for its fiscal year beginning April 1, 2008. This Statement did not have an impact on the Company’s financial position or results of operations.

~~Recent~~CONSOLIDATED ~~Accounting~~STATEMENTS ~~Pronouncements~~OF ~~Not~~CASH ~~Yet Adopted~~FLOWS

InFOR ~~December~~THE ~~2007,~~YEARS ~~the~~ENDED ~~FASB~~JUNE ~~issued SFAS No. 160~~30, ~~“Non-controlling~~2010 ~~Interests~~AND in Consolidated Financial Statements”. The standard requires all entities to report non-controlling (minority) interests as equity in consolidated financial statements. SFAS No. 160 eliminates the diversity that currently exists in accounting for transactions between an entity and non-controlling interests by requiring they be treated as equity transactions SFAS No. 160 is effective for financial statements issued for fiscal years beginning on or after December 15, 2008. Early adoption is prohibited. The Company does not expect there to be any significant impact on its financial position, cash flows and results of operations.2009

	Year ended June 30,
	2010			2009
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:

CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(1,019,897	)	$	(236,903	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation		798			799
Reorganization Costs		199,673			–
Loss on Stock Issuances		186,159			–
Stock and debt issued for interest and services		391,482			–
Changes in Assets and Liabilities:
Deposits		4,520			–
Inventory		(17,364	)		11,168
Prepaids		(179,814	)		–
Accounts receivable and employee advances		(12,327	)		10,491
Accounts payable and advances		153,846			71,114
Accrued interest		(16,651	)		39,312

NET CASH USED IN OPERATING ACTIVITIES		(309,575	)		(104,019	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Overdraft borrowings (repayment)		(830	)		2,053
Repayment on notes payable, related party		(48,033	)		(42,675	)
Repayment on notes payable		(114,107	)		(5,000	)
Proceeds from borrowings		471,518			149,641

NET CASH PROVIDED BY FINANCING ACTIVITIES		308,548			104,019

CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from reorganization		1,027			–

NET CASH PROVIDED BY INVESTING ACTIVITIES		1,027			–

NET CHANGE IN CASH & CASH EQUIVALENTS		–			–

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		–			–

CASH AND CASH EQUIVALENTS AT JUNE 30, 2010 AND 2009	$	–		$	–

Supplemental disclosure of cash flow information:

Cash paid during the year for:
Interest	$	30,755		$	18,230
Income Taxes	$	–		$	–
Non-cash transactions:
Common stock paid for services		329,036			–
Common stock paid for interest		62,446			–
Common stock paid for debt		437,012			–

~~Note~~The 2accompanying notes are an integral part of these consolidated financial statements.

~~Summary of Significant Accounting Policies – (cont’d)~~21

~~New~~Table ~~Accounting~~of ~~Standards – (cont’d)~~Contents

~~Recent~~Index ~~Accounting~~to ~~Pronouncements~~Financial ~~Not Yet Adopted – (cont’d)~~Statements

InSUNRIDGE ~~May 2008~~INTERNATIONAL, ~~the FASB issued SFAS No~~INC. 162, The Hierarchy of Generally Accepted Accounting Principles (“SFAS No. 162”). SFAS No. 162 is intended to improve financial reporting by identifying a consistent framework, or hierarchy, for selecting accounting principles to be used in preparing financial statements that are presented in conformity with U.S. generally accepted accounting principles for nongovernmental entities. SFAS No. 162 is effective 60 days following the SEC's approval of the Public Company Accounting Oversight Board Auditing amendments to AU Section 411, The Meaning of Present Fairly in Conformity with Generally Accepted Accounting Principles. The Company does not expect there to be any significant impact of adopting SFAS 162 on its financial position, cash flows and results of operations.

InNOTES ~~May~~TO ~~2008,~~CONSOLIDATED ~~the~~FINANCIAL FASB issued FSP No. APB 14-1, “Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)” (“FSP APB 14-1”). FSP APB 14-1 applies to convertible debt instruments that, by their stated terms, may be settled in cash (or other assets) upon conversion, including partial cash settlement, unless the embedded conversion option is required to be separately accounted for as a derivative under SFAS 133. Convertible debt instruments within the scope of FSP APB 14-1 are not addressed by the existing APB 14. FSP APB 14-1 requires that the liability and equity components of convertible debt instruments within the scope of FSP APB 14-1 be separately accounted for in a manner that reflects the entity’s nonconvertible debt borrowing rate. This requires an allocation of the convertible debt proceeds between the liability component and the embedded conversion option (i.e., the equity component). The difference between the principal amount of the debt and the amount of the proceeds allocated to the liability component will be reported as a debt discount and subsequently amortized to earnings over the instrument’s expected life using the effective interest method. FSP APB 14-1 is effective for the Company’s fiscal year beginning January 1, 2009 and will be applied retrospectively to all periods presented. The Company does not expect there to be any significant impact on its financial position, cash flows and results of operations.STATEMENTS

21NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

~~Note~~Ophthalmic 2International, Inc. (“OI”) was incorporated in March 1997 in the state of Nevada. OI had been a wholly owned subsidiary of Coronado Industries, Inc. until January 26, 2007, when OI and its subsidiaries were purchased from Coronado Industries, Inc. for cash and other consideration.

~~Summary~~Tari, Inc. (“Tari”) was incorporated on May 2, 2001 under the laws of ~~Significant~~the ~~Accounting~~State ~~Policies~~of –Nevada ~~(cont~~and located in Toronto, Ontario, Canada. The accounting and reporting policies of Tari conform to accounting principles generally accepted in the United States of America. Tari’d)s fiscal year end was March 31.

~~New~~In ~~Accounting~~September ~~Standards~~2009, –Tari consummated an Agreement of Share Exchange and Plan of Reorganization (~~cont’d~~the “Agreement”) with OI. Pursuant to the Agreement, Tari agreed to issue an aggregate of 33,050,000 shares of its restricted common stock to the shareholders of OI in exchange for all the issued and outstanding common stock shares of OI.

~~Recent~~The ~~Accounting~~exchange ~~Pronouncements~~of ~~Not~~shares ~~Yet~~has ~~Adopted~~been –accounted for as a reverse acquisition in the form of a recapitalization with OI as the “accounting acquirer.” Prior to the acquisition, Tari changed its name to SunRidge International, Inc. (~~cont’d~~hereinafter referred to as “SunRidge” or the “Company”). Following the acquisition, OI became the wholly-owned subsidiary of SunRidge. SunRidge has adopted a fiscal year end of June 30. Operations after the acquisition have been based in Fountain Hills, Arizona, where the Company manufactures and markets a patented Vacuum Fixation Device and patented suction rings to major medical supply companies and health care providers throughout the world. As a recapitalization, the accompanying financial statements represent the activity of OI.

InGOING June 2008, the FASB ratified the consensus reached on EITF Issue No. 07-05, “Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock.” EITF Issue No. 07-05 clarifies the determination of whether an instrument (or an embedded feature) is indexed to an entity’s own stock, which would qualify as a scope exception under SFAS No. 133. EITF Issue No. 07-05 is effective for financial statements issued for fiscal years beginning after December 15, 2008. Early adoption for existing instruments is not permitted. The Company does not believe that the pending adoption of EITF Issue No. 07-05 will have a material effect on the Company’s financial statementsCONCERN

~~On May 28, 2009,~~ The ~~Financial~~Company’s Accounting Standards Board (FASB) issued FASB Statement No. 165, Subsequent Events (“FSAB 165”). This Statement is intended to establish general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are ~~issued~~presented oron ~~are~~a ~~available~~going toconcern bebasis, ~~issued. It~~which ~~requires~~contemplates the ~~disclosure~~realization of ~~the~~assets ~~date through which an entity has evaluated subsequent events~~ and the ~~basis~~satisfaction ~~for~~of ~~that~~liabilities ~~date—that~~in ~~is, whether that date represents~~ the ~~date~~normal ~~the~~course ~~financial~~of ~~statements were issued or were available to be issued~~business. ~~This~~ ~~disclosure~~The ~~should~~Company ~~alert all users of financial statements that an entity~~ has not ~~evaluated~~made ~~subsequent~~an ~~events~~operating ~~after~~profit ~~that~~since ~~date~~1996. inFurther, the ~~set~~Company ofhas ~~financial~~a ~~statements~~working ~~being~~capital ~~presented.~~deficit ~~FSAB~~of ~~165~~$(638,457) isand ~~effective~~a ~~for~~negative ~~interim~~net ~~and~~worth ~~annual~~of ~~periods~~$(14,085,616) ~~ending~~as ~~after~~of June 1530, ~~2009.~~2010, ~~FSAB~~which ~~165~~causes isa ~~not~~doubt ~~expected~~about tothe ~~have~~ability ~~any~~of ~~impact on~~ the Company’s ~~financial~~to ~~position~~remain ora ~~results~~going ~~from operations~~concern.

~~Note~~The 3financial statements do not include any adjustments to reflect the possible future effects of the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the uncertainty of the Company’s ability to continue as a going concern.

~~Fair~~NOTE ~~Value~~2 ~~Measurements~~– SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

~~The~~PRINCIPLES ~~Company~~OF adopted SFAS No. 157 on April 1, 2008 for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). SFAS No. 157 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. CONSOLIDATION

~~SFAS~~The ~~No.~~consolidated ~~157~~financial ~~defines~~statements ~~fair~~include ~~value as~~ the ~~price~~financial ~~that~~position, ~~would~~results ~~be received upon sale~~ of anoperations, ~~asset~~cash orflows ~~paid~~and ~~upon~~changes ~~transfer of a liability~~ in anstockholders’ ~~orderly~~equity ~~transaction~~(deficit) ~~between~~of ~~market participants at~~ the ~~measurement~~Company ~~date~~ and inits ~~the~~wholly ~~principal~~owned ~~or most advantageous market for that asset or liability~~subsidiary. ~~The~~All ~~fair~~material ~~value~~intercompany ~~should be calculated based on assumptions that market participants would use in pricing the asset or liability~~transactions, ~~not~~accounts onand ~~assumptions~~balances ~~specific~~have tobeen ~~the entity~~eliminated. ~~In addition, the fair value of liabilities should include consideration of non-performance risk including the Company’s credit risk.~~

~~Note~~Table 3of Contents

~~Fair~~Index ~~Value~~to ~~Measurements~~Financial ~~– (cont’d)~~Statements

InSUNRIDGE ~~addition to defining fair value~~INTERNATIONAL, ~~SFAS No~~INC. 157 expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

~~Level~~NOTES 1TO –CONSOLIDATED ~~inputs~~FINANCIAL ~~are based upon unadjusted quoted prices for identical instruments traded in active markets.~~STATEMENTS

~~Level~~NOTE 2 – ~~inputs~~SUMMARY ~~are~~OF ~~based~~SIGNIFICANT ~~upon~~ACCOUNTING ~~quoted~~POLICIES prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.(Continued)

~~Level~~USE 3OF –ESTIMATES ~~inputs~~IN ~~are~~THE ~~generally~~PREPARATION ~~unobservable~~OF ~~and~~FINANCIAL typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.STATEMENTS

The ~~Company~~preparation ~~holds~~of nofinancial ~~Level~~statements 1in orconformity ~~Level~~with 2accounting ~~financial~~principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets orand liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, depreciable lives, realization of net operating losses, and valuation of stock-based transactions.

~~The~~CASH ~~carrying~~AND ~~value~~CASH of cash, accounts payable and accrued liabilities, advance payable and due to related parties approximate their fair value because of the demand or short term to maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.EQUIVALENTS

23Cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less.

~~Note 4~~INVENTORIES

~~Advances~~Inventories ~~Payable~~consist primarily of materials and parts and are stated at the lower of cost, as determined on a first-in, first-out (FIFO) basis, or market.

~~The~~ACCOUNTS ~~advances payable to a non-related party are unsecured, non-interest bearing and have no specific terms for repayment.~~ RECEIVABLE

~~Note~~The 5Company follows the allowance method of recognizing uncollectible accounts receivable. The allowance method recognizes bad debt expense as a percentage of accounts receivable based on a review of the individual accounts outstanding and the Company’s prior history of uncollectible accounts receivable. As of June 30, 2010 and 2009, the Company has not established an allowance for uncollectible accounts receivable. The Company does not record interest income on delinquent receivable balances until it is received. Accounts receivable are generally unsecured.

~~Related~~The ~~Party~~Company ~~Transactions~~ had one significant customer accounting for 89% and 0% of total revenues during the year sended June 30, 2010 and 2009. There were no accounts receivable from this customer at June 30, 2010 and 2009.

~~The~~PROPERTY ~~Company~~AND ~~was charged the following by a director of the Company:~~EQUIPMENT

						(Cumulative)
						May 2,
						2001 (Date of
		Years ended				Inception) to
		March 31,				March 31,
		2009		2008		2009
Management fees	$	6,000	$	6,000	$	28,500

Property and equipment are stated at cost. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to operations as incurred. Betterments or renewals are capitalized when incurred. Depreciation is provided using accelerated methods over the following useful lives:

Included in accounts payable and accrued liabilities at March 31, 2009 is $28,500 (March 31, 2008: $22,500) of unpaid management fees due to a director of the Company.

	Office furniture & Equipment		5 – 7 Years
	Machinery		5 – 7 Years
	Leasehold Improvements		5 Years

~~Note 6~~23

~~Due~~Table toof ~~Related Party~~Contents

~~The~~Index ~~amount due~~ to ~~related~~Financial ~~party, the director of the Company, consists of unpaid advances. The amount due is unsecured, non-interest bearing and has no specific terms for repayment.~~Statements

~~Subsequent~~SUNRIDGE ~~to March 31~~INTERNATIONAL, ~~2009, the director of the Company advanced $5,000 to the Company~~INC. ~~The advance is unsecured, non-interest bearing and has no specific terms of repayment.~~

24NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~Note~~NOTE 72 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

~~Deferred~~LONG-LIVED ~~Tax Assets~~ASSETS

~~The~~We ~~Company's~~review ~~income~~long-lived ~~tax~~assets for ~~expense~~impairment ~~for~~whenever events or changes in circumstances indicate that the ~~years~~carrying ~~ended~~amount ~~March~~of ~~31,~~an ~~2009~~asset ~~and~~may ~~2008~~not ~~differed~~be ~~from~~recoverable. Assets to be disposed of are reported at the ~~United~~lower ~~States~~of ~~statutory~~carrying ~~rates:~~amount or fair value less cost to sell.

		2009			2008
Effective tax rate		35	%		35	%
Statutory rate applied to loss before income taxes	$	(10,200	)	$	(14,211	)
Change in valuation allowance		10,200			14,211
Income tax expense	$	-		$	-

DEFERRED INCOME TAXES

~~The~~Deferred ~~significant~~income ~~components~~taxes are provided on an asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when in the ~~Company’s~~opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are asadjusted ~~follows:~~for the effects of changes in tax laws and rates on the date of enactment.

		2009			2008
Deferred tax assets
Net operating losses carryforward	$	91,000		$	80,659
Less: valuation allowance		(91,000	)		(80,659	)
Deferred tax assets	$	-		$	-

LOSS PER SHARE

AtBasic ~~March~~loss ~~31,~~per ~~2009,~~share ~~the~~includes ~~Company~~no ~~has~~dilution ~~incurred~~and ~~accumulated~~is ~~net~~computed ~~operating~~by ~~losses~~dividing inloss to common stockholders by the ~~United~~weighted ~~States~~average number of ~~America~~common ~~totalling~~shares ~~approximately~~outstanding ~~$260,000~~for ~~which~~the ~~are~~period. The ~~available~~effect toof ~~reduce~~the ~~taxable~~recapitalization ~~income~~is included in ~~future~~all ~~taxation~~periods ~~years~~presented.

25Assumed conversion of a convertible promissory note for approximately 160,000 shares at June 30, 2010 has been excluded from the calculation of diluted net loss per common share as its effect would be anti-dilutive (decreases the loss per share). In addition, as the Company has a net loss available to common stockholders for the fiscal years ended June 30, 2010 and 2009, the diluted EPS calculation has been excluded from the financial statements.

~~Note~~FAIR 7VALUE OF FINANCIAL INSTRUMENTS

~~Deferred~~The ~~Tax~~carrying ~~Assets~~values –of ~~(cont’d)~~our financial instruments included in current assets and current liabilities approximated their respective fair values at each balance sheet date due to the immediate or short-term maturity of these financial instruments.

~~These~~RECENT ~~losses~~ACCOUNTING ~~expire as follows:~~PRONOUNCEMENTS

Year of Expiry		Amount
2022	$	40,000
2023		28,000
2024		18,000
2025		24,000
2026		38,000
2027		42,000
2028		41,000
2029		29,000
	$	260,000

With the exception of those discussed below, there have been no recent accounting pronouncements or changes in accounting pronouncements during the fiscal year ended June 30, 2010, that are of significance, or potential significance, to us.

The amount taken into income as deferred tax assets must reflect that portion of the income tax loss carryforwards that is more-likely-than-not to be realized from future operations. The Company has chosen to provide an allowance of 100% against all available income tax loss carryforwards, regardless of their time of expiry.24

26Table of Contents

~~Note~~Index 7to Financial Statements

~~Deferred~~SUNRIDGE ~~Tax~~INTERNATIONAL, ~~Assets – (cont’d)~~INC.

~~Uncertain~~NOTES ~~Tax~~TO ~~Positions~~CONSOLIDATED FINANCIAL STATEMENTS

~~The~~NOTE ~~Company~~2 ~~has~~– ~~adopted~~SUMMARY ~~FASB~~OF ~~Interpretation~~SIGNIFICANT ~~No.~~ACCOUNTING ~~48,~~POLICIES ~~"Accounting for Uncertainty in Income Taxes"~~ (~~"FIN 48"~~Continued). FIN 48 prescribes a recognition threshold and measurement attribute for the recognition and measurement of tax positions taken or expected to be taken in income tax returns. FIN 48 also provides guidance on de-recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, and accounting for interest and penalties associated with tax positions.

~~The~~In ~~Company~~October ~~files~~2009, ~~income~~the ~~tax~~FASB ~~returns~~issued inguidance ~~the~~on Urevenue recognition for multiple-deliverable revenue arrangements.S. ~~federal~~The ~~jurisdiction,~~guidance ~~various~~is ~~state~~effective ~~and~~prospectively ~~foreign~~for ~~jurisdictions. The~~revenue ~~Company’s~~arrangements ~~tax~~entered ~~returns~~into ~~are~~or ~~subject~~materially tomodified ~~tax~~in ~~examinations~~fiscal byyears ~~U.S.~~beginning ~~federal~~on ~~and~~or ~~state~~after ~~tax~~June ~~authorities~~15, or2010 ~~examinations~~and byaddresses ~~foreign~~how ~~tax~~to ~~authorities~~separate ~~until~~deliverables ~~respective~~and ~~statue~~how ofto ~~limitation. It~~measure isand ~~subject~~allocate arrangement consideration to ~~tax~~one ~~examinations~~or bymore ~~tax~~units ~~authorities~~of ~~for~~accounting. ~~all~~The ~~taxation~~Company ~~years~~is ~~commencing~~currently assessing the impact of this guidance on orits ~~after~~financial ~~2003~~position and results of operations.

~~Management’s~~REVENUE analysis of FIN 48 supports the conclusion that the Company does not have any accruals for uncertain tax positions as of March 31, 2009. As a result, tabular reconciliation of beginning and ending balances would not be meaningful. If interest and penalties were to be assessed, we would charge interest to interest expense, and penalties to other operating expense. It is not anticipated that unrecognized tax benefits would significantly increase or decrease within 12 months of the reporting date.RECOGNITION

The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, our price is infixed ~~arrears~~or determinable, and collection is reasonably assured. We recognize revenue on ~~filing~~our ~~its~~standard ~~statutory~~products ~~income~~when ~~tax~~title ~~returns~~passes ~~and~~to the customer upon shipment. The standard products do not have customer acceptance criteria. The Company has standard rights of return that are accounted for as a warranty provision, although it is ~~therefore~~deemed immaterial at this time. The Company does not have any price protection agreements or other post shipment obligations. For custom equipment where customer acceptance is part of the sales agreement, revenue will be recognized when the customer has ~~estimated~~accepted the ~~expected~~product. ~~amount~~In cases where custom equipment does not have customer acceptance as part of ~~loss~~the ~~carry~~sales ~~forwards~~agreement, ~~available~~revenue ~~once~~will be recognized upon shipment, as long as the ~~outstanding~~system ~~returns~~meets ~~are~~the ~~filed~~specifications as agreed upon with the customer. ~~The~~ ~~Company~~Certain ~~expects~~transactions tomay have ~~significant~~multiple ~~net~~deliverables, ~~operating~~with ~~loss~~the ~~carry~~deliverables ~~forwards~~clearly ~~for~~defined. ~~income~~To ~~tax~~the ~~purposes~~extent ~~available~~that tothe ~~offset~~secondary ~~future~~deliverables ~~taxable~~are ~~income~~other than perfunctory, the Company will recognize the revenue on each deliverable as it is delivered, if separable, or on the completion of all deliverables, if not separable.

27NOTE 3 – DEBT AND DEBT CONVERSION

~~ITEM~~From 9July 1, 2009 to June 30, 2010, the Company received $619,711 of investment in exchange for promissory notes. These ~~CHANGES~~promissory INnotes ~~AND~~were ~~DISAGREEMENTS~~for ~~WITH~~a ~~ACCOUNTANTS~~duration ONof ~~ACCOUNTING~~one ~~AND~~month ~~FINANCIAL~~to ~~DISCLOSURE~~one year with an interest rate of 10% for the term and a default rate of 12%.

~~None~~The Company offered the promissory note holders the opportunity to convert their principal and accrued interest into restricted common stock of the Company at various times during the fiscal year ended June 30, 2010.

~~ITEM~~The ~~9A(T): CONTROLS~~first ~~AND~~conversion ~~PROCEDURES~~took place March 31, 2010 at the closing bid stock price of $.30 cents per share and converted $302,553 of principal and interest.

~~Management’s~~Additional ~~Report~~conversions ontook ~~Disclosure~~place ~~Controls~~between April 1, 2010 and ~~Procedures~~June 30, 2010, at the closing bid stock prices between $.33 and $.20 cents per share and converted $205,310 of principal and interest.

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our president and treasurer (who is acting as our principal executive officer, principal financial officer, and principle accounting officer), to allow for timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. As of March 31, 2009, the end of our fiscal year covered by this report, we carried out an evaluation, under the supervision and with the participation of our president and treasurer (who is acting as our principal executive officer, principal financial officer, and principle accounting officer) of the effectiveness of the design and operation of our disclosure controls and procedures. Based on their evaluation, our president and treasurer (who is acting as our principal executive officer, principal financial officer, and principle accounting officer) concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance’s with US generally accepted accounting principles 25

~~Management’s~~Table ~~Report~~of ~~on Internal Control over Financial Reporting~~Contents

~~Management~~Index isto ~~responsible~~Financial for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Our management evaluated, under the supervision and with the participation of our principal executive and principal financial officer, the effectiveness of our internal control over financial reporting as of March 31, 2009.Statements

~~Based~~SUNRIDGE ~~on its evaluation under the framework in Internal Control—Integrated Framework~~INTERNATIONAL, issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management, with the participation of our principal executive and principal financial officer concluded that our internal control over financial reporting was effective as of March 31, 2009INC.

28NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~This~~NOTE 4 ~~annual~~– report does not include an attestation report of our company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our company’s independent registered public accounting firm pursuant to temporary rules of the SEC that permit our company to provide only management’s report in this annual report.EQUITY

~~Our~~Preferred management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and all fraud. A control system no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within a company are detected. The inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistakes. Controls can also be circumvented by the individual acts of some persons, or by collusion of two or more people. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.Stock

~~Changes~~As inof ~~Internal~~June ~~Control~~30, ~~over~~2010, ~~Financial~~our ~~Reporting~~authorized preferred stock is 50,000,000 shares of preferred stock with par value of $0.001 per share. The Company’s Board of Directors has the authority to divide the preferred stock shares into series and to fix the voting powers, designation, preference, and relative participating, option or other special rights, and the qualifications, limitations, or restrictions of the shares of any series so established. The Company has issued no preferred stock shares as of June 30, 2010.

~~There~~ Common were no changes in our internal control over financial reporting during the three months ended March 31, 2009 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.Stock

~~ITEM~~In 9BSeptember 2009, Tari, Inc. ~~OTHER~~completed ~~INFORMATION~~a 5-for-1 forward stock split which brought the shares outstanding of Tari, Inc. from 3,890,000 to 19,450,000. The 5-for-1 forward split has been accounted for retroactively for all periods presented.

~~None~~The President of Tari, Inc. contributed 12,500,000 shares of common stock to the Company as part of the exchange of shares with OI.

~~PART~~In ~~III~~September, 2009, Tari consummated an Agreement of Share Exchange and Plan of Reorganization (the “Agreement”) with OI. Pursuant to the Agreement, Tari agreed to issue an aggregate of 33,050,000 shares of its restricted common stock to all of the shareholders of OI in exchange for all the issued and outstanding common stock of OI.

~~ITEM~~During 10the year ended June 30, 2010, the Company issued 1,160,855 shares of common stock totaling $329,036 to various consultants and vendors for services performed. ~~DIRECTORS~~During the year ended June 30, ~~EXECUTIVE~~2010, ~~OFFICERS~~the Company also issued 1,781,325 ~~AND~~of ~~CORPORATE~~shares ~~GOVERNANCE~~of common stock totaling $507,865 to various note holders for payment of principal and interest.

Name	Age	Position with Registrant	Served as a Director or Officer since
Theodore Tsagkaris	60	President, Secretary, Treasurer, Chief Executive Officer, and Director (Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer)	September 26, 2002

NOTE 5 – LOSS ON STOCK ISSUANCES

The ~~following~~Company’s ispromissory note holders were given an incentive to convert the promissory notes to common stock by issuing the stock at a ~~biographical~~discount ~~summary~~from ofthe Mrclosing bid trade price. ~~Theodore~~As ~~Tsagkaris:~~such, the Company recorded a loss on stock issuances of $186,159 on 2,901,093 shares of stock as of June 30, 2010.

~~Mr.~~NOTE ~~Tsagkaris~~6 – ~~has~~RELATED ~~acted~~PARTY as our president, chief executive officer, principal accounting officer and as a director since September 26, 2002. Mr. Tsagkaris graduated in 1974 from the Winnipeg Red River College with a degree in the Hospitality Industry. In 1984, he graduated from the University of Toronto with a degree in Economics and Political Science. For the last ten years, Mr. Tsagkaris has been self-employed marketing consultant. TRANSACTIONS

29From July 1, 2009 to June 30, 2010, G. Richard Smith, the Company's President and a Director, loaned the Company an additional $70,647 and was repaid $57,397. This debt bears an interest rate of 10% for the term and 12% default per annum after and is due on demand. At June 30, 2010, G. Richard Smith was owed $225,099 by the Company.

~~ITEM~~During ~~11: EXECUTIVE~~the ~~COMPENSATION~~year ended June 30, 2010 the following transactions occurred:

~~The~~Gary ~~table~~R. ~~below~~Smith, ~~summarizes~~the ~~all~~Company's ~~compensation~~Chief ~~awarded~~Financial ~~to,~~Officer ~~earned~~and byTreasurer, orwas ~~paid~~repaid tohis ~~our~~loans ~~executive~~of ~~officers~~$12,500 byand ~~any~~accrued ~~person~~interest ~~for all services rendered in all capacities to us for the fiscal year ended March 31, 2009~~thereon.

		Annual Compensation				Long Term Compensation
Name (1)	Title	Year	Salary	Bonus	Other Annual Compensation	Restricted Stock Awarded	Options/ SARs (#)	LTIP payouts ($)	All Other Compensation
Theodore Tsagkaris	President/Secretary/ Treasurer	2006 2007 2008	$0 $0 $0	0 0 0	$6,000 $6,000 $6,000	0 0 0	0 0 0	0 0 0	0 0 0
		2009	$0	0	$6,000	0	0	0	0

~~ITEM~~Table ~~12: SECURITY~~of ~~OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS~~Contents

~~The~~Index ~~following table sets forth information regarding the beneficial ownership of our shares of common stock at March 31, 2009 by (i) each person known by us~~ to beFinancial the beneficial owner of more than 5% of our outstanding shares of common stock, (ii) each of our directors, (iii) our executive officers, and (iv) by all of our directors and executive officers as a group. Each person named in the table, has sole voting and investment power with respect to all shares shown as beneficially owned by such person and can be contacted at our executive office address.Statements

TITLE OF CLASS	NAME OF BENEFICIAL OWNER	SHARES OF COMMON STOCK	PERCENT OF CLASS
Common	Theodore Tsagkaris	2,500,000	64.3%

SUNRIDGE INTERNATIONAL, INC.

~~ITEM~~NOTES ~~13: CERTAIN~~TO ~~RELATIONSHIPS~~CONSOLIDATED ~~AND~~FINANCIAL ~~RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE~~STATEMENTS

~~During~~NOTE ~~the fiscal year ended March 31, 2009, we accrued $~~6~~,000~~ – toRELATED ~~our~~PARTY ~~president,~~TRANSACTIONS ~~Theodore Tsagkaris for management services.~~ (Continued)

~~Except~~On ~~for~~March ~~Theodore~~31, ~~Tsagkaris~~2010, noThe ~~other~~Smith ~~shareholder~~Foundation, orInc., ~~related~~a ~~party~~charitable ~~holds~~foundation ~~more~~of ~~than~~which ~~10%~~G. ofRichard Smith, the ~~voting~~Company's ~~rights~~President ~~attached~~and toa ~~all~~Director, ofis ~~our~~President, ~~outstanding~~was issued 49,600 shares of restricted common stock in conversion of $12,000 in loans and accrued interest thereon.

~~Our~~On ~~management~~March is31, ~~involved in other business activities and may~~2010, inJohn ~~the future become involved in other business opportunities. If a specific business opportunity becomes available~~Sharkey, ~~such persons may face~~ a ~~conflict~~Director inof ~~selecting between our business and their other business interests. In~~ the ~~event~~Company, ~~that~~was aissued ~~conflict~~97,121 shares of ~~interest~~restricted ~~arises~~common atstock ain ~~meeting~~conversion of ~~our directors~~$29,136 aof ~~director~~expense ~~who~~he ~~has~~incurred ~~such~~on abehalf ~~conflict~~of ~~will~~the ~~disclose~~Company ~~his interest~~ in ~~a proposed transaction and will abstain from voting for or against the approval of such transaction~~2007.

30On April 18, 2008, Marston & Webb, Inc. loaned Ophthalmic International $20,000. This loan bears an interest rate of 12% per annum and is due on demand. On September 29, 2009, Victor Webb, a principal on Marston & Webb, Inc., became a Director of the Company. At March 31, 2010, Marston & Webb, Inc. was issued 79,671 shares of restricted common stock for the $20,000 of principal and $3,901 of accrued interest thereon.

~~ITEM~~Between 14January 1, 2010 and June 30, 2010, we received loans in the total amount of $323,352 from five non-affiliated sources and our President. $190,500 ~~PRINCIPAL~~of ~~ACCOUNTING~~this ~~FEES~~amount ~~AND~~was ~~SERVICES~~used to pay off the debt owed to third parties and Theodore Tsagkaris, our prior President, Secretary, Treasurer, as required by the agreement between Ophthalmic International, Inc. and the Company. After the payments of these debts, Mr. Tsagkris resigned as a Director of the Company, effective February 11, 2010.

~~Our~~An ~~principal~~employee ~~accountants,~~had ~~BDO~~received ~~Dunwoody~~money ~~LLP~~in advance of a business trip, ~~billed~~however, the ~~following~~trip ~~fees~~was ~~for~~canceled the ~~services~~funds ~~indicated:~~are to be paid back to the Company in the amount of $3,400.

		March 31, 2009		March 31, 2008
Audit fees	$	18,795	$	12,382
Audit-related fees	$	Nil	$	Nil
Tax fees	$	Nil	$	Nil
All other fees	$	Nil	$	Nil

As of June 30, 2010 and 2009, notes payable to related parties consisted of the following:

Audit fees consist of fees related to professional services rendered in connection with the audit of our annual financial statements and the review of the financial statements included in each of our quarterly reports on Form 10-Q.

	June 30,
	2010			2009

10% for the first 90 days and 12% per annum, thereafter, note payable to stockholders, principal and interest due on demand, secured by the assets of the Company	$	203,976		$	258,726

18% per annum note payable to a stockholder, principal and interest due on demand; unsecured		–			11,000
		203,976			269,726
Less: Current Portion		(203,976	)		(269,726	)
	$	–		$	–

Our audit committee’s policy is to pre-approve all audit and permissible non-audit services performed by the independent accountants. These services may include audit services, audit-related services, tax services and other services. Under our audit committee’s policy, pre-approval is generally provided for particular services or categories of services, including planned services, project based services and routine consultations. In addition, the audit committee may also pre-approve particular services on a case-by-case basis. Our audit committee approved all services that our independent accountants provided to us in the past two fiscal years.27

~~ITEM~~Table ~~15: EXHIBITS,~~of ~~FINANCIAL STATEMENT SCHEDULES~~Contents

3.1	Articles of Incorporation*
3.2	By-Laws*
31.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Index to Financial Statements

* previouslySUNRIDGE ~~filed as an exhibit to our registration statement on Form SB-2~~INTERNATIONAL, ~~as amended~~INC.

~~SIGNATURES~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~Pursuant~~ NOTE to7 ~~the~~– ~~requirements~~PROPERTY ofAND ~~Section 13 and 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.~~EQUIPMENT

~~Tari~~At June 30, ~~Inc.~~2010 and 2009, property and equipment consisted of the following:

/s/ Theodore Tsagkaris

	June 30,
	2010			2009

Office furniture and equipment	$	58,433		$	58,433
Machinery and equipment		15,613			15,613
Leasehold improvements		3,000			3,000
		77,046			77,046
Less: accumulated depreciation		(74,175	)		(73,377	)
Net property and equipment	$	2,871		$	3,669

~~---------------------------~~Depreciation expense was $798 and $799, for the years ended June 30, 2010 and 2009, respectively.

~~Theodore~~NOTE ~~Tsagkaris~~8 – INVENTORY

~~President,~~As ~~Secretary,~~of ~~Treasurer~~June 30, ~~Chief~~2010 ~~Executive~~and ~~Officer~~2009, ~~and~~inventory ~~Director~~consisted of the following:

(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

	June 30,
	2010		2009

Raw materials	$	15,502	$	3,556
Finished goods		5,418		–
	$	20,920	$	3,556

~~Dated: June 23, 2009~~28

31Table of Contents

~~Exhibit~~Index ~~31.1~~to Financial Statements

~~CERTIFICATION~~SUNRIDGE INTERNATIONAL, INC.

I,NOTES ~~Theodore~~TO ~~Tsagkaris,~~CONSOLIDATED ~~President~~FINANCIAL ~~and Chief Executive Officer of Tari Inc., certify that:~~STATEMENTS

1. NOTE 9 – COMMITMENTS AND CONTINGENCIES

IOperating ~~have reviewed this annual report on Form 10-K of Tari Inc.;~~Leases

2The Company entered into a non-cancelable lease agreement for office space in Fountain Hills, Arizona commencing December 1, 2004, through December 15, 2009. Monthly rental payments were $4,520. After the lease expired, the Company extended the lease to December 31, 2010, at a monthly rate of $4,520. There is no immediate plan to sign a new rental agreement. As of December 31, 2009, the Company had been delinquent in its rent payments. In order to make up past due payments, the Company issued a promissory note dated January 27, 2010 to convert $70,308.83 in rent and related late and legal fees into a note to pay $17,627 in four quarterly payments for a total principal amount of $70,308.83, including interest at 12% per annum after July 1, 2010. As of June 30, 2010, the Company had not made all the payments required and were in default on the note.

Based on my knowledge, this annual report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;Indemnification

3The Company has agreed to indemnify its officers and directors for certain events or occurrences that may arise as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. However, the Company believes the estimated fair value of these indemnification agreements is minimal and has no liabilities recorded for these agreements as of June 30, 2010 and 2009.

~~Based~~Contingent on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;Liability

4The Company had a consulting agreement with Francesco Aspes whereby a clause stated that the Company would reimburse Mr. Aspes for documented expenses, up to a maximum of 80,000 euros (or $109,000 USD currently). There is a claim by Mr. Aspes for the maximum amount, however, the Company believes that it is more than reasonably possible that the reimbursement claim is unenforceable. As such, there is no accrued expense related to the potential reimbursement, as no underlying documentation in support of this claim has been received.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:29

a)Table of Contents

~~Designed~~Index ~~such disclosure controls and procedures, or caused such disclosure controls and procedures~~ to beFinancial designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;Statements

b)SUNRIDGE INTERNATIONAL, INC.

~~Designed~~NOTES ~~such~~TO ~~internal~~CONSOLIDATED ~~control~~FINANCIAL over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;STATEMENTS

c NOTE 9 – COMMITMENTS AND CONTINGENCIES (Continued)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andLitigation

dOn December 16, 2009, the Company's patent attorneys, Meschkow & Gresham, P.L.C., filed a lawsuit (CV 2009-037698) in the Superior Court for Maricopa County, Arizona against the Company and Mr. Richard Smith for breach of contract in the failure to pay for legal services in the amount of $12,063 plus costs and legal fees. The Company's answer to the complaint admitted that legal services had been provided but claimed no knowledge of the value of those services. This case was transferred to arbitration and an award was rendered in the amount of $8,064 against G. Richard Smith, our President and Director, his wife, Karen Smith and the Ophthalmic International, Inc., our wholly owned subsidiary, plus court costs of $453 and attorney fees of $1,500. This arbitration award has not been filed with the Clerk of the Court to proceed to judgment yet.

~~Disclosed~~During inour ~~this~~fourth ~~report~~quarter ~~any~~2010, ~~change~~Charles E. Brokup filed a lawsuit (CV 2010-054295) in ~~the~~Superior ~~registrant's~~Court ~~internal~~for ~~control~~Maricopa ~~over~~County, ~~financial~~Arizona ~~reporting~~against ~~that~~Ophthalmic ~~occurred~~International, ~~during~~Inc. ~~the~~and ~~registrant's~~Mr. ~~most~~G. ~~recent~~Richard ~~fiscal~~Smith ~~quarter~~for ~~(the~~breach ~~small~~of ~~business~~promise ~~issuer's~~to ~~fourth~~pay ~~fiscal~~$10,000 ~~quarter~~principal on a promissory note and $1,000 per month in ~~the~~interest. ~~case~~The ofCompany's ananswer ~~annual~~to ~~report)~~the complaint admitted that ~~has~~the ~~materially~~principal ~~affected~~amount of $10,000 orwas isowed ~~reasonably~~but ~~likely~~denies tothat ~~materially~~more ~~affect,~~than ~~the~~legal ~~registrant's~~interest ~~internal~~is ~~control~~owed ~~over~~after ~~financial~~the ~~reporting;~~first ~~and~~month expressly stated interest of $1,000.

3230

5.Table of Contents

~~The~~Index ~~registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,~~ to ~~the~~Financial ~~registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):~~Statements

a)SUNRIDGE INTERNATIONAL, INC.

~~All~~NOTES ~~significant~~TO ~~deficiencies~~CONSOLIDATED ~~and~~FINANCIAL material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; andSTATEMENTS

b) NOTE 10 – NOTES PAYABLE

~~Any~~As ~~fraud,~~of ~~whether~~June ~~or not material~~30, ~~that~~2010 ~~involves~~and ~~management~~2009, ornotes ~~other~~payable ~~employees~~consisted ~~who~~of ~~have a significant role in~~ the ~~registrant's internal control over financial reporting.~~following:

Date: June 23, 2009


	June 30,
	2010		2009
Convertible Note Payable:

10% per annum note payables to XL Lending, principal and interest payable on demand; includes an option to convert into approximately 160,000 shares of the Company’s common stock based on the bid price of the common stock at time of payment.	$	38,000	$	–

/s/ Theodore Tsagkaris

Notes Payable:

15% per annum note payable to Vickie Goulette, principal and interest payable on demand.		60,000			60,000

15% per annum note payables to Robert Suliot, principal and interest payable on demand.		100,000			95,000

10% for the first 90 days and 12% per annum, thereafter note payable to Victor Webb, principal and interest payable on demand. (1)		–			20,000

10% for the first 90 days and 12% per annum, thereafter note payables to XL Lending, principal and interest payable on demand.		12,000			32,000

10% for the first 90 days and 12% per annum, thereafter note payables to Harvey Wish, principal and interest payable on demand.		16,000			2,300

10% for the first 90 days and 12% per annum, thereafter note payable to Larry Belcamino, principal and interest payable on demand.		–			6,000

10% for the first 90 days and 12% per annum, thereafter note payable to Charles Brokof, principal and interest payable on demand.		10,000			–

12% per annum note payable to Pettibone Properties, principal and interest payable in four quarterly installments.		57,202			–
		293,202			215,300
Less: Current Portion		(293,202	)		(215,300	)
	$	–		$	–

~~--------------------------------~~______________________

~~Theodore~~(1) ~~Tsagkaris~~Victor Webb became a Director of the Company during fiscal 2010 and is now considered a related party.

~~President,~~The ~~C.E.O.~~above ~~and~~notes ~~Director~~are secured by the assets of the Company.

~~(Principal Executive Officer)~~31

33Table of Contents

~~Exhibit~~Index ~~31.2~~to Financial Statements

~~CERTIFICATION~~SUNRIDGE INTERNATIONAL, INC.

I,NOTES ~~Theodore~~TO ~~Tsagkaris,~~CONSOLIDATED ~~President~~FINANCIAL ~~and Chief Executive Officer of Tari Inc., certify that:~~STATEMENTS

1. NOTE 11 – INCOME TAXES

IThe ~~have~~Company's ~~reviewed~~income ~~this~~tax ~~annual~~expense ~~report~~for onthe ~~Form~~years ~~10-K~~ended ofJune ~~Tari~~30, ~~Inc.;~~2010 and 2009 differed from the United States statutory rates:

	June 30,
	2010			2009

Effective tax rate, Combination Federal and State		40%			40%

Statutory rate applied to loss before income taxes	$	407,000		$	95,000
Change in valuation allowance		(407,000	)		( 95,000	)
Income tax expense	$	–		$	–

~~Based~~The onsignificant mycomponents ~~knowledge, this annual report does not contain any untrue statement~~ of ~~material fact or omit to state a material fact necessary to make~~ the ~~statements~~Company’s ~~made,~~deferred intax ~~light~~assets ofare ~~the~~as ~~circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;~~follows:

	June 30,
	2010			2009
Deferred tax assets
Net operating losses carryforward	$	608,000		$	201,000
Less: Valuation allowance		(608,000	)		(201,000	)
Deferred tax assets	$	–		$	–

~~Based~~The onamount mytaken ~~knowledge,~~into ~~the~~income ~~financial~~as ~~statements,~~deferred ~~and~~tax ~~other~~assets ~~financial~~must ~~information~~reflect ~~included~~that inportion ~~this~~of ~~annual~~the ~~report,~~income ~~fairly~~tax ~~present~~loss incarryforward ~~all~~that ~~material~~is ~~respects~~more ~~the~~likely ~~financial~~than ~~condition,~~not ~~results~~to ofbe realized from future operations. The ~~and~~Company ~~cash~~has ~~flows~~chosen ofto ~~the~~provide ~~registrant~~an asallowance of, ~~and~~100% ~~for,~~against ~~the~~all ~~periods~~available ~~presented~~income intax ~~this~~loss ~~annual~~carry-forward, ~~report;~~regardless of their time of expiration.

4At June 30, 2010, the Company has incurred accumulated net operating losses in the United States of America totaling approximately $1,522,000 which are available to reduce taxable income in future taxation years, subject to statutory time limitations.

~~The~~Losses ~~registrant's~~expire ~~other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (~~as ~~defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have~~follows:

	Year of Expiration		Amount
	Federal	State	Federal		State

Year End: June 30,	2028	2013	$	267,000	$	267,000
	2029	2014		237,000		237,000
	2030	2015		1,020,000		1,020,000
			$	1,524,000	$	1,524,000

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;32

b)Table of Contents

~~Designed~~Index ~~such internal control over financial reporting, or caused such internal control over financial reporting~~ to beFinancial designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;Statements

c)SUNRIDGE INTERNATIONAL, INC.

~~Evaluated~~NOTES ~~the~~TO ~~effectiveness~~CONSOLIDATED ofFINANCIAL the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andSTATEMENTS

d)NOTE 12 – SUBSEQUENT EVENTS

~~Disclosed~~Stock in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and Issuances

34Between July 1, 2010 and November 11, 2010, the Company issued the following restricted common stock: (i) 105,578 shares for $16,800 of services by one Non-Accredited Investor, as defined by SEC Rule 501; (ii) 432,058 shares in conversion of $72,750 of debt and accrued interest by six Non-Accredited Investors; (iii) 700,000 shares for $144,000 of public relations services by three Non-Accredited firms; (iv) 890,909 shares to three Non-Accredited Investors for $51,000 cash; and (v) 259,091 shares for $27,500 of consulting services by two Non-Accredited Investors. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.

5.Litigation

~~The~~During ~~registrant's~~the ~~other~~first ~~certifying~~quarter ~~officer(s)~~of fiscal ~~and~~year I2011, ~~have~~Francesco ~~disclosed~~Aspes, ~~based~~our onformer ~~our~~European ~~most~~marketing ~~recent~~consultant, ~~evaluation~~filed ofa ~~internal~~lawsuit ~~control~~(CV ~~over~~2010-028530) ~~financial~~in ~~reporting~~the Superior Court for Maricopa County, toArizona against the ~~registrant's~~Company ~~auditors~~for ~~and~~failure ~~the~~to ~~audit~~pay ~~committee~~him $180,000 of ~~the~~employee ~~registrant's~~wages ~~board~~earned previously plus 80,000 Euros of ~~directors~~expenses ~~(or~~incurred ~~persons~~as ~~performing~~an employee of the ~~equivalent~~Company. ~~functions):~~Our answer to this complaint has not yet been filed.

a)33

~~All~~Table ~~significant deficiencies and material weaknesses in the design or operation~~ of ~~internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and~~Contents

b)Index to Financial Statements

~~Any~~ITEM ~~fraud,~~9. ~~whether~~CHANGES orIN ~~not~~AND ~~material,~~DISAGREEMENTS ~~that~~WITH ~~involves~~ACCOUNTANTS ~~management~~ON orACCOUNTING ~~other~~AND ~~employees~~FINANCIAL ~~who have a significant role in the registrant's internal control over financial reporting.~~DISCLOSURE

~~Date:~~During ~~June~~the 23registrant’s two most recent fiscal years and any subsequent interim period, ~~2009~~there were no disagreements with accountants on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreement(s) if not resolved to the satisfaction of the former accountants would have caused them to make reference to the subject matter of the disagreement(s) in connection with their reports. The former accountants’ reports for the period of their engagement did not contain an adverse opinion or disclaimer of opinion. However the former accountants’ reports were each modified for uncertainty whether the registrant would continue as a going concern. There was no qualification or modification as to audit scope or accounting principles.

~~/s/~~ITEM ~~Theodore~~9A. ~~Tsagkaris~~CONTROLS AND PROCEDURES

~~--------------------------------~~Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

~~Theodore~~Under ~~Tsagkaris~~the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the Exchange Act). Accordingly, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act were not effective as of June 30, 2010 to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, and summarized and reported within the time periods specified in SEC rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.

~~Secretary~~With the participation of the Company’s Chief Executive Officer and Chief Financial Officer, ~~Treasurer~~management &conducted Can evaluation of the effectiveness of our internal control over financial reporting as of June 30, 2010, based on the framework and criteria established in Internal Control – Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).~~F.O.~~

~~(Principal~~A ~~Financial~~material ~~Officer~~weakness is a significant deficiency, or combination of significant deficiencies, that result in more than a remote likelihood that a material misstatement of the annual or interim financial statements will occur and not be detected by management before the financial statements are published. In its assessment of the effectiveness in internal control over financial reporting as of June 30, 2010, the Company determined that there were control deficiencies that constituted material weakness, as described below.

~~Principal~~ We ~~Accounting~~have ~~Officer)~~not tested the operating effectiveness of our controls over financial reporting. However due to time and staff constraints, we did not test our controls over financial reporting in accordance with COSO standards. Since we have not completely tested our controls, we have determined that our controls over financial reporting were ineffective.

35The Company did not maintain a sufficient complement of personnel with the appropriate level of knowledge, experience, and training to analyze, review, and monitor the accounting of year end adjustments that are significant or non-routine. This material weakness resulted in errors in the preliminary June 30, 2009 consolidated financial statements and more than a remote likelihood that a material misstatement of the Company’s annual or interim financial statements would not be prevented or detected.

~~Exhibit 32.1~~34

~~CERTIFICATION~~Table ~~PURSUANT~~of TOContents

18Index ~~U.S.C.~~to ~~SECTION~~Financial ~~1350~~Statements

ASDue ~~ADOPTED~~to ~~PURSUANT~~these TOmaterial weaknesses, management concluded that our internal control over financial reporting was not effective as of June 30, 2010.

~~SECTION~~This ~~906~~annual OFreport ~~THE~~does ~~SARBANES-OXLEY~~not ~~ACT~~include OFan ~~2002~~attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Managements report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.

InThe ~~connection with the Annual Report of Tari Inc. (the “~~Company”) onis ~~Form~~in ~~10-K for~~ the ~~year~~process ~~ended~~of ~~March~~developing ~~31, 2009 as filed with the Securities~~ and ~~Exchange~~implementing ~~Commission~~a onremediation ~~the~~plan ~~date~~to ~~hereof~~address (the ~~“Report”),~~material ~~the~~weaknesses ~~undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350,~~ as ~~adopted~~described ~~pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:~~above.

1.The Company has taken the following actions to improve internal control over financial reporting:

~~The~~During ~~Report~~the ~~fully~~remaining ~~complies~~period ~~with~~through the ~~requirements~~year ofending ~~Section~~June ~~13(a)~~30, or2011, ~~15(d)~~we ofintend ~~the~~to ~~Securities~~devoteresources, ~~Exchange~~to ~~Act~~properlyassess, ofand ~~1934;~~remedy if needed, our control environment and entity-level controls.
2During the remaining period through the year ending June 30, 2011, we will enhance our risk assessment, internalcontrol design and documentation and develop a plan for testing inaccordance with COSO standards.

~~The~~In ~~information~~light ~~contained~~of inthe aforementioned material weaknesses, management conducted a thorough review of all significant or non-routine adjustments for the ~~Report~~year ~~fairly~~ended ~~presents~~June 30, 2010. As a result of this review, management believes that there are no material inaccuracies or omissions of material fact and, to the best of its knowledge, believes that the consolidated financial statements for the year ended June 30, 2010 fairly present in all material respects, the financial condition and results of operations offor the Company in conformity with U.S. generally accepted accounting principles.

~~Date: June~~Inherent ~~23,~~Limitations ~~2009~~Over Internal Controls

~~/s/~~Internal ~~Theodore~~control ~~Tsagkaris~~over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations, including the possibility of human error and circumvention by collusion or overriding of controls. Accordingly, even an effective internal control system may not prevent or detect material misstatements on a timely basis. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

~~--------------------------------~~Changes in Internal Control Over Financial Reporting.

~~Theodore~~We ~~Tsagkaris~~have made no change in our internal control over financial reporting during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

~~President,~~ITEM C9B.~~E.O.~~ ~~and~~OTHER ~~Director~~INFORMATION

~~(Principal~~Not ~~Executive Officer)~~applicable.

3635

~~Exhibit~~Table ~~32.2~~of Contents

~~CERTIFICATION~~Index ~~PURSUANT~~to TOFinancial Statements

18PART ~~U.S.C. SECTION 1350~~III

ASITEM ~~ADOPTED~~10. ~~PURSUANT~~DIRECTORS, TOEXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

~~SECTION~~Directors ~~906~~and OFExecutive ~~THE~~Officers ~~SARBANES-OXLEY~~of ~~ACT OF 2002~~SunRidge

In connection with the ~~Annual~~Share ~~Report~~Exchange ofAgreement, ~~Tari~~we ~~Inc~~appointed G. ~~(the~~Richard ~~“Company”)~~Smith, onPresident, ~~Form~~Chief ~~10-K~~Executive ~~for~~Officer ~~the~~and ~~year~~a ~~ended~~director ~~March~~of 31the Company, ~~2009~~Gary R. Smith as ~~filed~~Chief ~~with~~Financial ~~the~~Officer, ~~Securities~~Treasurer and ~~Exchange~~Secretary, ~~Commission~~John onSharkey ~~the~~as ~~date~~a ~~hereof~~director ~~(the~~and ~~“Report”),~~Victor ~~the~~Webb ~~undersigned~~as a director. Furthermore, inconcurrent with the ~~capacities~~Closing ~~and~~Date onof the ~~dates~~Share ~~indicated~~Exchange ~~below~~Agreement, ~~hereby~~Mr. ~~certifies~~Theodore ~~pursuant~~Tsagkaris, toour 18sole ~~U.S.C.~~officer ~~Section~~and ~~1350~~Director, asresigned ~~adopted~~from ~~pursuant~~his toofficer ~~Section~~positions, ~~906~~but ofremained ~~the~~as ~~Sarbanes-Oxley~~a ~~Act~~Board ofmember. On ~~2002~~February 11, ~~that~~2010, toMr. ~~his~~Tsagkaris ~~knowledge:~~resigned as a Director of the Company.

1The following table furnishes information concerning the officers and Directors of the Company as of June 30, 2010, and their business backgrounds for at least the last five years. Executive officers are elected annually by our Board of Directors. Each executive officer holds his office until he resigns, is removed by the Board, or his successor is elected and qualified. Directors are elected annually by our stockholders at the annual meeting. Each director holds his office until his successor is elected and qualified or his earlier resignation or removal.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

Name	Age	Position

G. Richard Smith	63	Chief Executive Officer, President, and Director
Gary R. Smith	67	Chief Financial Officer, Treasurer, Secretary
John Sharkey	54	Director
Victor Webb	71	Director

2G. Richard Smith – From January 2007 to September 2009, Mr. Smith was the President, Treasurer, Secretary and sole Director of OI. From 1996 to January 2007, Mr. Smith was Chairman, Secretary, Director and a principal shareholder of Coronado Industries, Inc., the former parent of OI and a publicly traded company. Coronado Industries, Inc. changed its name to Continental Fuels, Inc. in 2007.

~~The~~Gary ~~information~~R. ~~contained~~Smith in– ~~the~~From ~~Report~~1996 ~~fairly~~to ~~presents~~January 2007, inMr. ~~all~~Smith ~~material~~was ~~respects~~Vice President, ~~the~~Treasurer, ~~financial~~Director ~~condition~~ and ~~results~~a ofprincipal ~~operations~~shareholder of Coronado Industries, Inc., the ~~Company~~former parent of OI and a publicly traded company. Coronado Industries, Inc. changed its name to Continental Fuels, Inc. in 2007.

~~Date: June 23, 2009~~36

~~/s/ Theodore~~Table ~~Tsagkaris~~of Contents

~~------------------------------~~Index to Financial Statements

~~Theodore~~Dr. ~~Tsagkaris~~John Sharkey– Dr. Sharkey, was the Director of Operations for Ophthalmic International from 2003 to 2007, and now the Vice President, Business Development and Alliance Management for Sciele Pharma, Inc. from 2007 to present. Dr. Sharkey, is a business and healthcare technology executive with 20 years experience worldwide in the pharmaceutical and medical device industry. He has a strong track record in pharmaceutical and medical device development, business development, operations and project management in a global healthcare environment. Dr. Sharkey also has the ability to identify and implement innovative solutions to complex business and technical problems. With a practical background in both large, multinational and small start-up business environments and extensive international experience, he has headed multi-cultural, cross-functional business and technical teams to repeated, successful outcomes.

~~Secretary~~Victor Webb– Mr. Webb joined Dow Jones in 1964 and left in 1983 during which time he was European Director, ~~Treasurer~~then &International CDirector after which he was made the Managing Director of Dow Jones International Marketing Services and Vice President for Dow Jones International.F He left Dow Jones in 1983 and established Marston Webb International, an agency with offices in New York, Los Angeles and with affiliate agencies in most major cities throughout the world.O From 1983 to the present, he has been a managing partner in Marston Webb International. He is also presently a Director of PAC International which is a firm that is developing the Marshall Islands.

~~(Principal~~Employment ~~Financial~~Agreements ~~Officer~~of ~~and~~the Executive Officers

~~Principal~~We ~~Accounting~~have ~~Officer)~~not entered into any employment agreements with any employees.

37Indemnification of Officers and Directors

The General Corporation Law of Nevada provides that directors, officers, employees or agents of Nevada corporations are entitled, under certain circumstances, to be indemnified against expenses (including attorneys’ fees) and other liabilities actually and reasonably incurred by them in connection with any suit brought against them in their capacity as a director, officer, employee or agent, if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal action or proceeding, if they had no reasonable cause to believe their conduct was unlawful. This statute provides that directors, officers, employees and agents may also be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by them in connection with a derivative suit brought against them in their capacity as a director, if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made without court approval if such person was adjudged liable to the corporation.

Our by-laws provide that we shall indemnify our officers and directors in any action, suit or proceeding unless such officer or director shall be adjudged to be derelict in his or her duties.

Code of Ethics

We currently do not have a code of ethics that applies to our officers, employees and directors, including our Chief Executive Officer.

Table of Contents

Index to Financial Statements

Conflicts of Interest

Certain potential conflicts of interest are inherent in the relationships between our officers and directors, and us.

From time to time, one or more of our affiliates may form or hold an ownership interest in and/or manage other businesses both related and unrelated to the type of business that we own and operate. These persons expect to continue to form, hold an ownership interest in and/or manage additional other businesses which may compete with ours with respect to operations, including financing and marketing, management time and services and potential customers. These activities may give rise to conflicts between or among the interests of us and other businesses with which our affiliates are associated. Our affiliates are in no way prohibited from undertaking such activities, and neither we nor our shareholders will have any right to require participation in such other activities.

Further, because we intend to transact business with some of our officers, directors and affiliates, as well as with firms in which some of our officers, directors or affiliates have a material interest, potential conflicts may arise between the respective interests of us and these related persons or entities. We believe that such transactions will be effected on terms at least as favorable to us as those available from unrelated third parties.

With respect to transactions involving real or apparent conflicts of interest, we have adopted policies and procedures which require that: (i) the fact of the relationship or interest giving rise to the potential conflict be disclosed or known to the directors who authorize or approve the transaction prior to such authorization or approval, (ii) the transaction be approved by a majority of our disinterested outside directors, and (iii) the transaction be fair and reasonable to us at the time it is authorized or approved by our directors.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s Directors and executive officers, and persons who own more than 10% of a registered class of the Company’s equity securities to file with the Securities and Exchange Commission (“SEC”) initial reports of ownership and reports of changes in ownership of equity securities of the Company. Officers, Directors and shareholders holding greater than 10% are required to furnish the Company with copies of all Section 16(a) forms they file. To the Company's knowledge, G. Richard Smith has not filed a Form 3 with respect to the shares of the Company’s common stock he received upon the completion of the Share Exchange Agreement. To the Company's knowledge, John Sharkey has not filed a Form 3 with respect to the shares of the Company’s common stock he received upon the completion of the Share Exchange Agreement or a Form 4 with respect to the 97,121 shares of the Company’s common stock he received on March 31, 2010. To the Company's knowledge, Victor Webb has not filed a Form 3 with respect to the shares of the Company’s common stock he received upon the completion of the Share Exchange Agreement or a Form 4 with respect to the 79,671 shares of the Company’s common stock he received on March 31, 2010. To the Company's knowledge, Gary R. Smith has not filed a Form 3 reporting that he does not beneficially own any shares of the Company's common stock upon being appointed as Chief Financial Officer of the Company.

Table of Contents

Index to Financial Statements

Audit Committee Financial Expert

The Company’s Board of Directors does not have an “audit committee financial expert,” within the meaning of such phrase under applicable regulations of the Securities and Exchange Commission, serving on its audit committee. Like many small companies, it is difficult for the Company to attract and retain Board members who qualify as “audit committee financial experts.”

Nominating Committee

The full Board of Directors of the Company functions as a nominating committee to select potential additional Directors of the Company. The Board has not specifically designated a separate nominating committee because all members of the Board of Directors desire to be involved in the selection of any new Director.

ITEM 11.

EXECUTIVE COMPENSATION

The table below discloses the compensation of the chief executive officer of the Company during the two fiscal years ended June 30, 2010:

Summary Compensation Table

The following table sets forth information concerning cash and non-cash compensation paid by the Company to its executive officers for each of the two fiscal years ended June 30, 2010 and 2009. The table below sets forth the positions for each person. All amounts are in USD.

Name and Principal Position	Year	Salary ($)		Bonus ($)		Stock Award ($)		Option Award ($)		Non-Equity Incentive Plan Compensation Earnings ($)		Non-Qualified Deferred Compensation Earnings ($)		All other Compensation ($)		Total ($)

Theodore Tsagkaris, Former Chief Executive Officer and Chief Financial Officer (1)	2010 2009		0 0		0 0		0 0		0 0		0 0		0 0		0 6,000		0 6,000
G. Richard Smith, Chief Executive Officer (2)	2010 2009		0 0		0 0		0 0		0 0		0 0		0 0		0 0		0 0
Gary R. Smith, Chief Financial Officer (3)	2010 2009		0 0		0 0		0 0		0 0		0 0		0 0		0 0		0 0

__________

(1)	On September 29, 2009, we acquired Ophthalmic International, Inc. in a Share Exchange Agreement and in connection with that transaction, Theodore Tsagkaris tendered his resignation as CEO and CFO but remained as a Director until February 11, 2010.
(2)	In connection with the acquisition of Ophthalmic International, Inc. on September 29, 2009, G. Richard Smith was elected as the Chief Executive Officer and a Director of the Company.
(3)	In connection with the acquisition of Ophthalmic International, Inc. on September 29, 2009, Gary R. Smith was elected as the Chief Financial Officer and a Director of the Company.

Table of Contents

Index to Financial Statements

Option Grants

We do not currently have any equity incentive or stock option plans. Accordingly, we did not grant options to purchase any equity interests to any employees or officers, and no stock options are issued or outstanding to any officers at June 30, 2010. However, we may adopt such plans in the future.

Employment Contracts

There are no employment agreements between the Company and its officers and directors.

Compensation Committee, Interlocks and Insider Participation

The full Board of Directors of the Company functions as a compensation committee. The Board has not specifically designated a separate compensation committee due to the relatively small size of the Company.

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information as of November 11, 2010, with respect to the beneficial ownership of the Company’s common stock by each executive officer and Director of the Company and each person known by the Company to be the beneficial owner of more than 5% of the Company’s outstanding shares of common stock.

Name, Address and Position of Beneficial Owner (1)	Amount and Nature of Beneficial Ownership (2)	Percentage of Class (3)

G. Richard Smith	28,092,500	62.7%
John Sharkey	1,749,621	3.9%
Victor Webb	1,732,171	3.8%
Gary R. Smith	0	0%

All directors and executive officers as a group (4 persons)	31,574,292	69.7%

_______________

(1)	The address of our officers and Directors is c/o SunRidge International, Inc., 16857 E. Saguaro Blvd., Fountain Hills, Arizona 85268.

(2)

Except as otherwise indicated, we believe that the beneficial owners of the common stock listed above, based on information furnished by such owners, have sole investment and voting power with respect to such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of common stock subject to options or warrants currently exercisable, or exercisable within 60 days, are deemed outstanding for purposes of computing the percentage ownership of the person holding such options or warrants, but are not deemed outstanding for purposes of computing the percentage ownership of any other person. The inclusion herein of such shares listed as beneficially owned does not constitute an admission of beneficial ownership.

(3)	Based on 45,329,816 shares of common stock outstanding as of November 11, 2010.

Table of Contents

Index to Financial Statements

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

No officer, Director, nominee for Director, or associate of any such officer, Director or nominee has been, since the beginning of the last fiscal year, or is presently indebted to the Company. There have been no transactions since the beginning of the Company’s last fiscal year, nor are there any proposed transactions, in which any officer, Director, nominee or principal securityholder has a direct or indirect material interest, except as follows:

From January 2007 through June 30, 2007, our President, G. Richard Smith, and his family members, loaned OI $88,500. $11,000 of these loans bear an annual interest rate of 18% and the remainder bear an annual interest rate of 12%. All of these loans are due on demand or prior to June 30, 2010.

From July 1, 2007 through June 30, 2008, G. Richard Smith and his family members loaned OI an additional $211,060. $11,000 of these loans bear an annual interest rate of 18% and the remainder bear an annual interest rate of 12%. All of these loans are due on demand or prior to June 30, 2010. G. Richard Smith received repayments of loans of $16,500 during the year. During fiscal year 2008, the Company paid $3,440 on an automobile loan for a member of G. Richard Smith’s family.

From July 1, 2008 through June 30, 2009, G. Richard Smith and his family loaned OI an additional $49,341. $11,000 of these loans bear an annual interest rate of 18% and the remainder bear an annual interest rate of 12%. All of these loans are due on demand or prior to June 30, 2010. G. Richard Smith received loan repayments of $42,675 during the year. During fiscal year 2009, the Company paid $2,815 on an automobile loan for a member of G. Richard Smith’s family. At June 30, 2009, G. Richard Smith was owed $186,726 by OI and Gary R. Smith, our Secretary/Treasurer, was owed $12,500 by OI.

As of June 30, 2009, Theodore Tsagkaris, our prior President, Secretary, and Treasurer, who continued as a Director of the Company following the closing of the Share Exchange Agreement, was owed $138,193 for advances to the Company and $30,000 for accrued management fees. These debts were unsecured and non-interest bearing. The Share Exchange Agreement provided that these sums, and $21,812 of accounts payable owed to third parties, would be paid in three equal payments within four months of the closing of the Share Exchange Agreement. The Share Exchange Agreement also provided that upon the payment in full of these Company debts, Mr. Tsagkaris would resign as a Director of the Company. All of these Company debts were paid and Mr. Tsagkaris resigned as a Director on February 11, 2010.

During the fiscal year ended June 30, 2010, G. Richard Smith, the Company's President and a Director, loaned the Company an additional $70,647 and was repaid $57,397. This debt bears an interest rate of 12% per annum and is due on demand. At June 30, 2010, G. Richard Smith was owed $225,099 by the Company.

During the fiscal year ended June 30, 2010, Gary R. Smith, the Company's Chief Financial Officer and Treasurer, was repaid his loans of $12,500 and accrued interest thereon. On March 31, 2010, The Smith Foundation, Inc., a charitable foundation of which G. Richard Smith, the Company's President and a Director, is President, was issued 49,600 shares of restricted common stock in conversion of $12,000 in loans and accrued interest thereon. On March 31, 2010, John Sharkey, a Director of the Company, was issued 97,121 shares of restricted common stock in conversion of $29,136 of expense he incurred on behalf of the Company in 2007.

Table of Contents

Index to Financial Statements

On April 18, 2008, Marston & Webb, Inc. loaned Ophthalmic International $20,000. This loan bears an interest rate of 12% per annum and is due on demand. On September 29, 2009, Victor Webb, a principal on Marston & Webb, Inc., became a Director of the Company. At March 31, 2010, Marston & Webb, Inc. was issued 79,671 shares of restricted common stock for the $20,000 of principal and $3,901 of accrued interest thereon.

Between January 1, 2010 and June 30, 2010, we received loans in the total amount of $323,352 from five non-affiliated sources and our President. $190,500 of this amount was used to pay off the debt owed to third parties and Theodore Tsagkris, our prior President, Secretary, Treasurer, as required by the agreement between Ophthalmic International, Inc. and the Company. After the payments of these debts, Mr. Tsagkris resigned as a Director of the Company, effective February 11, 2010.

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

The following is a summary of the fees billed to us by Semple, Marchal & Cooper for professional services rendered for the years ended June 30, 2010 and 2009:

Service	2010		2009

Audit Fees	$	27,788	$	37,110
Audit-Related Fees		–		–
Tax Fees		–		–
All Other Fees		–		–
Total	$	27,788	$	37,110

Audit Fees. Consists of fees billed for professional services rendered for the audits of our consolidated financial statements, reviews of our interim consolidated financial statements included in quarterly reports, services performed in connection with filings with the Securities and Exchange Commission and related comfort letters and other services that are normally provided by Semple, Marchal & Cooper in connection with statutory and regulatory filings or engagements.

Tax Fees. Consists of fees billed for professional services for tax compliance, tax advice and tax planning. These services include assistance regarding federal, state and local tax compliance and consultation in connection with various transactions.

Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors. The Board is to pre-approve all audit and non-audit services provided by the independent auditors. These services may include audit services, audit-related services, tax services and other services as allowed by law or regulation. Pre-approval is generally provided for up to one year and any pre-approval is as to the particular service or category of services and is generally subject to a specific amount. The independent auditors and management are required to periodically report to the Board regarding the extent of services of the independent auditors in accordance with this pre-approval and the fees incurred to date. The Board may also pre-approve particular services on a case-by-case basis. The Board pre-approved 100% of the Company’s 2010 and 2009 audit fees, audit-related fees, tax fees, and all other fees.

Table of Contents

Index to Financial Statements

PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) (1) Financial Statements

The Consolidated Financial Statements of the Company are set forth in Item 8 of this Report as listed on the Index to Consolidated Financial Statements on Page 16 of this Report.

(a) (2) Financial Statement Schedules

All schedules are omitted because they are not applicable, or are not required, or because the required information is included in the Consolidated Financial Statements or notes thereto.

(a) (3) Exhibits

Exhibit No.		Description

2.1		Share Exchange Agreement, dated September 5, 2009, by and among Sunridge International Inc. and Ophthalmic International, Inc. (1)
3.1		Articles of Exchange filed with the Nevada Secretary of State on July 23, 2009 (2)
3.2		Certificate of Change filed with the Nevada Secretary of State on August 4, 2009 (3)
21		Subsidiaries of the Registrant *
31.1		Certification by Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act *
31.2		Certification by Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act *
32.1		Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act *
32.2		Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act *

__________________

*	Filed herewith.

(1)	Incorporated by reference to Exhibit 2.1 of the Company's Current Report on Form 8-K filed October 5, 2009.

(2)	Incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K filed October 5, 2009.

(3)	Incorporated by reference to Exhibit 3.2 of the Company's Current Report on Form 8-K filed October 5, 2009.

Table of Contents

Index to Financial Statements

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SUNRIDGE INTERNATIONAL, INC.

Date: November 15, 2010	By:	/s/ G. Richard Smith

		G. Richard Smith
		President and Chief Executive Officer (Principal Executive Officer)


Date: November 15, 2010	By:	/s/ Gary R. Smith

		Gary R. Smith
		Secretary/Treasurer, Chief Financial Officer (Principal Accounting Officer)

In accordance with the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Company and in the capacities and on the dates indicated:


Dated: November 15, 2010		/s/ G. Richard Smith

		G. Richard Smith – Chief Executive Officer and Director


Dated: November 15, 2010		/s/ Gary R. Smith

		Gary R. Smith – Chief Financial Officer


Dated: November 15, 2010		/s/ John Sharkey

		John Sharkey – Director




		Victor Webb – Director

Filing Compare · SUNRIDGE INTERNATIONAL, INC.